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ABSTRACT

There is a dearth of validated self-efficacy (SE) measures in the field of
preventive oncology. The objective of this study is to describe the development and
validation of a measure to assess patients’ perceived ability to obtain the recommended
care following an abnormality suspicious for breast cancer. Guided by a social cognitive
theory framework, a 51-item measure was developed to explore perceived capability to
obtain follow up care under a number of barriers. A multi-step process was utilized to
assess the instrument’s psychometric properties. First, cognitive validity assessments
with experts were conducted, and these aided in the wording refinement of several items.
An exploratory factor analysis was performed, and a 4-factor solution emerged
containing factors related to barriers to care such as costs, transportation, structural and
communication barriers. Reliability analyses were conducted for the total scale and
subscales. Then, relationships between theoretically-related constructs were explored to
assess convergent validity (self-efficacy and outcome expectations, perceived control),
and divergent validity (self-efficacy and depression). Findings provide evidence of both
convergent and discriminant validity. This multi-step process aided in the reduction of
the scale to 12 validated and reliable items.

vii

INTRODUCTION

Cancer is the second leading cause of death in the United States (Heron et al.,
2009). In fact, 1 of every 4 deaths is attributed to cancer, and in 2009, 1,500 people died
each day due to cancer. Breast and colorectal cancers are in the top three cancers that
affect both men and women. In 2009, the total number of new cases of breast and
colorectal cancer was estimated at 194,280 and 146,970 for both sexes respectively
(American Cancer Society, 2009).
Breast cancer is the most commonly diagnosed type of cancer in women. In 2009,
192,370 new cases of invasive breast cancer were estimated to occur in the US, and
12,650 new cases in Florida alone. Incidence rates have slightly (2.2%) decreased in the
last twenty years. Nevertheless, 40,170 breast cancer deaths in the US and 2,730 in
Florida were estimated, making breast cancer the second leading cause of death in
women in 2009.
Colorectal cancer is the third most common cancer for both men and women. In
2009, 146,970 new cases of colorectal cancer were estimated in the US, and 10,420 in
Florida alone. Incidence rates for colorectal cancer have also decreased in the last two
decades, 46.4 cases per 100,000 population in 2005, compared to 66.3 in 1985. This is
also due in part to an increase in screenings. As incidence rates decreased, so have
mortality rates; there was a 4.3% decrease per year from 2002 to 2005 for men and
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women. In 2009, there were 49,920 deaths in the US, and 3,460 in Florida for colorectal
cancer (American Cancer Society, 2009).
As shown by the cancer statistics, for breast and colorectal cancer incidence and
mortality rates have declined in the last 20 years. This is in part attributed to the increase
in screenings for early detection and treatment of cancers. For instance, bolstering
mammography utilization may prompt early detection of breast cancer, and increasing
colorectal cancer screenings may contribute to the detection and removal of polyps before
they develop into cancer. Thus, promotion and improvements on early detection are
essential to reduce cancer figures.
Unfortunately, cancer figures are not as promising when rates for underserved and
minority populations are examined. Individuals from minority groups are more likely to
have higher incidence rates from certain cancers than their white counterparts (National
Cancer Institute, 2007). In addition, poor and medically underserved populations have
higher cancer mortality rates and lower survival rates (American Cancer Society, 2008;
National Cancer Institute, 2007). In fact, African-American women are 1.2 times more
likely to die from cancer than white women (Gullatte, Phillips, & Gibson, 2006; Ward E,
Jemal A, Cokkinides V, & al., 2004). Studies have shown that only 33.7% of immigrant
women have had a mammogram within the last year, and only 41.4% within the last two
years (Ward E, et al., 2004). Other studies provide evidence that women who have
migrated to the US have lower rates of breast self-examination adherence when compared
to their US-born counter parts (Borrayo & Guarnaccia, 2000). The contributing factors to
these racial health disparities are complex, and it is difficult to single out a determining
cause for it. Socioeconomic status (SES) is one of the most influential factors in this
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issue. However, a person’s SES, i.e. income, education level, occupation, etc, is often tied
to other contributing factors to racial/ethnic disparities, such as access to care and barriers
(National Cancer Institute, 2007).
The health care system is complex and may be challenging for many patients.
Cancer screenings as mentioned above are essential in reducing cancer mortality.
However, navigating the health care system to obtain the needed care after an abnormal
cancer screening may prove to be quite challenging for many people. Patients are faced
with several barriers, and the literature has explored and documented many of these
variables including language and literacy barriers (Brown et al., 2011; Wolff et al., 2003),
transportation (Wolff, et al., 2003), distance to health care providers, lack of insurance
(Borrayo & Guarnaccia, 2000), financial difficulties, and self-efficacy (Carpenter &
Colwell, 1995).

Self-Efficacy
Self-efficacy is a construct, which stems from the Social Learning Theory (SLT),
developed by psychologist Albert Bandura (Bandura, 1986). Bandura began examining
and publishing his work on SLT in the early 60’s. He published his book Social
Foundations of Thought and Action: A Social Cognitive Theory in 1986, and began
exploring a construct that has now become a staple, and vital component, in most theories
of health behavior. The Health Belief Model, for instance, incorporates self-efficacy in
the model by addressing barriers to action (Becker & Rosenstock, 1987). The Theory of
Reasoned Action was extended to the Theory of Planned Behavior, by including a
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perceived behavioral control component (Ajzen, 1991). Other health behavior models
have incorporated self-efficacy as an essential component, as well.
According to Bandura, perceived self-efficacy refers to an individual judgment of
their capability to execute a behavior (Bandura, 1982a). This construct has been widely
explored as perceived capabilities function as determinants of human behavior. Bandura
asserted that people often avoid activities that they believe are hard to manage, and
undertake those activities that they judge as more manageable. Thus, judgments of
capability can determine the amount of effort that individuals put into a certain behavior
and how long they persist in the face of barriers (i.e. obstacles or aversive experiences).
Bandura’s theory also explored predictability of behavior based on perceived selfefficacy. His early research supports that perceived self-efficacy was a stronger predictor
of future behaviors than performance attainment. In other words, he found that people are
more influenced by how they perceive their success than their actual success (Bandura,
1982a). His early work sparked interest in many research arenas.
Self-efficacy has been explored in the education arena, as a mediator of academic
achievement (Rosenholtz & Rosenholtz, 1981); in the management arena to identify
factors that interfere with work type and work quality (King, Le Bas, & Spooner, 2000);
and in the disaster recovery arena to assess capabilities to manage recovery demands
following a natural disaster (Hyre et al., 2008). Assessments of self-efficacy in these
different areas have demonstrated that perceptions of capability in response to demands
of situations within a context are notably useful. Moreover, these assessments can
potentially benefit the quality of outcomes in their respective contexts.
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Similarly, the health area has explored self-efficacy in the context of health
behavior. Behavioral change is facilitated by a strong sense of personal efficacy (Bandura
1982a). Self-efficacy is believed to influence how people feel, think and behave. For
instance, in terms of feelings, individuals with lower self-efficacy may harbor more
pessimistic feelings about their personal accomplishments and, in turn, experience
psychopathologies such as depression and anxiety. In terms of cognition, individuals with
a strong sense of self-efficacy may experience better cognitive processes that facilitate a
sense of confidence that may enhance their motivations. Lastly, in terms of behavior,
individuals with high sense of self-efficacy may feel more confident about performing a
challenging task (Bandura, 1982a; Schwarzer & Reinhard, 1995).

Self-Efficacy & Health
A large body of literature demonstrates that self-efficacy is related to successful
health outcomes. Many studies have examined the role of self-efficacy in selfmanagement skills and chronic disease outcomes. In a study conducted by Clark and
Dodge, self-efficacy beliefs concerning an individual’s ability to exercise and diet were
associated with improved self-reports of health status, and a decrease in visits to
providers (Clark & Dodge, 1999). Similarly, improved health outcomes have been found
in studies exploring diabetes management (Aalto & Uutela, 1997). Furthermore, in
studies of relapse in smoking cessation, self-efficacy has been used to assess situations in
which individuals experience most difficulty in avoiding smoking. In a study, participants
judged their ability to remain abstinent in ‘high risk’ situations, and self-efficacy
assessments were used to predict outcomes following a behavioral treatment program.
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When smoking rates were examined at follow-up, self-efficacy was significantly
associated with smoking status at 3-months (r=-.50), 6-months (r=-.36) and 1-yr follow
up (r=-.15). Overall, 79% of participants with high self-efficacy scores had congruent
changes in smoking behavior; in other words, higher self efficacy was associated with
reduced smoking, and lower self-efficacy was associated with increase in smoking
(Colletti, Supnick, & Payne, 1985). In addition, self-efficacy research has been conducted
in other health-related areas including eating disorders, pain management, cardiac
rehabilitation, negotiation of safer sex practices, exercise and physical activity
motivation, and nutrition and weight control (O'Leary, 1985; Schwarzer, 1992;
Schwarzer & Reinhard, 1995) .

Self-Efficacy Measurement
It is evident that capturing self-efficacy as it relates to health outcomes is of high
clinical value. Several instruments to gauge self-efficacy have emerged in the last two
decades. Researchers have developed tools to assess self-efficacy as it relates to disease
management such as chronic obstructive pulmonary disease (COPD), asthma, arthritis,
diabetes and heart failure (Frei, Svarin, Steurer-Stey, & Puhan, 2009). Some examples
include self-efficacy scales to explore compliance in utilization of hearing aids (West &
Smith, 2007), to explore the moderating effects of self-efficacy on empowerment of
abused women (May & Limandri, 2004), and to assess self-efficacy of recovery demands
faced by domestic violence victims (Benight, Ironson, & Durham, 1999). Measuring
self-efficacy requires the development of an instrument that is specific to a situation,

6

disease, population or characteristic (Bandura, 2006). Hence, the plethora of self-efficacy
measures in the literature.

Dimensions of Self-Efficacy
The construct of self-efficacy can be measured in three dimensions: magnitude,
strength, and generality. “Magnitude” refers to expected performance attainments and
ordering of tasks by level of difficulty. For example, a person with low-magnitude
expectations feels able to perform simpler tasks, whereas a person with high-magnitude
expectations feels more capable to perform more difficult tasks. “Strength” has to do with
the confidence in attaining each expected level (i.e. a person’s judgment of how certain
he/she is to perform a specific task). For example, a person with weak expectations of
mastery of a specific task is less confident in performing such task, contrary to a person
with strong expectations. “Generality” refers to the extent to which a person’s efficacy
expectations about a task or behavior may not generalize to other situations or
experiences. (Bandura, 1977, 1982a, 1982b; O'Leary, 1985). To exemplify generality, a
person may be confident to exercise under supervised conditions (e.g. at a health club),
but their self-efficacy may not have generality outside these supervised conditions (e.g. at
home). As discussed above, each of these dimensions has important implications on
performance. In terms of measurement, each of these self-efficacy dimensions can be
measured by different procedures. For example, individuals may rank performance
activities by various levels of difficulty (magnitude), they can rate the activities that they
believe can perform based on their confidence (strength), or they can gauge their
capability to perform a certain behavior in other situations (generality).
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Sources of Efficacy Information
There are four major sources of self-efficacy expectations: performance
accomplishments, vicarious experience, verbal persuasion, and physiological feedback.
First, performance accomplishments refer to learning through personal experience, and
are considered the most powerful source of efficacy. A task or behavior that is learned
through personal experience is achieved by overcoming difficulty or fears, and refining
and mastering a behavior or task. Such mastery of behavior results in an increase in selfefficacy and acquisition of coping mechanisms used to deal with obstacles required to
master the behavior at hand (Bandura, 1986).
The second source of efficacy is vicarious experience, which refers to learning
through observation of other people, referred as ‘models’. Models illustrate the desired
behavior. It is important that the model is perceived by the observer to have overcome
difficulty through determination and hard work, so that the model affects the observer
positively. In addition, positive efficacy effects are believed to be stronger if the model
and the observer share common characteristics (Bandura, 1986).
The third source of efficacy is verbal persuasion. Here, individuals are verbally
encouraged to perform a behavior and persevere in the efforts to change or maintain it.
Verbal persuasion is a widely used method in the context of health education. Adoption
of health promoting-behaviors and refraining from health-impairing behaviors proves to
be a challenging task for many individuals, especially in terms of disease management
(Bandura, 1986). Research under this domain explores the moderating and mediating
effects of self-beliefs as predictors of behavior (Schwarzer & Reinhard, 1995).
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Lastly, physiological feedback is the fourth source of efficacy expectations.
Bandura asserted that high physiological arousal can potentially impair performance
(Bandura, 1986), which is in line with studies that examined the relationship between
perceived self-efficacy and depression, anxiety, feelings of hopelessness and low selfesteem (Locke & Latham, 1990) .
Although there are various sources of efficacy expectations, each of them do not
directly and solely affect perceived self-efficacy. Individuals gather and process
information from all of these sources, and the sources act as mediators of the impact of
self-efficacy on behavior. It is important to understand that efficacy is influenced by
many other factors, and that often times, other psychological concepts may influence selfefficacy expectations. Some of these concepts include health locus of control, selfesteem, anxiety, depression, and coping mechanisms. It is important to note, that
although these constructs influence self-efficacy, marked distinctions exists amongst
these psychological constructs and the construct of self efficacy. Strecher and colleagues
(1986) reviewed and explained these concepts and their distinction as follows. First, locus
of control is an expectation that one’s health is controlled by external forces beyond one’s
control, whereas self-efficacy has to do with one’s perceived capability to perform a
desired behavior. Next, self-esteem refers to self-worth, whereas self-efficacy is an
evaluation of one’s capability to perform under specific situations. Then, anxiety and
depression deal with feelings about inefficacy to deal with events or get certain outcomes,
whereas self-efficacy assesses one’s performance of a desired behavior, not whether one
can perform that behavior without feelings of anxiety or depression. Lastly, coping is
considered a process of assessment of one’s possibilities in face of adversity, whereas
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self-efficacy is an assessment of one’s capabilities to perform a desired behavior in face
of adversity (Strecher, DeVellis, Becker, & Rosenstock, 1986).
Self efficacy as described above is a seminal construct in models of health
behavior and a critical factor in the assessment of health behavior. There has been an
increased interest in the measurement of this construct in the field of behavioral health
research as it is helpful to identify barriers to care, to detect differences among diverse
groups, and most importantly, to aid in the prediction of health behavior. Many
instruments have been developed to explore the role of self-efficacy as it relates to
chronic disease prevention and control, including in the field of oncology.

Self-Efficacy & Oncology
For many years the field of behavioral oncology has tried to understand the
intricate psychosocial factors related to cancer. Cancer is a prevalent chronic disease and
there are many behavioral and social factors that influence cancer health outcomes.
Cancer prevention is among the Healthy People 2020 Objectives. Specifically, increasing
the proportion of adults that are counseled about the current cancer prevention guidelines,
and increasing the number of adults who receive colorectal and breast cancer screenings
(C-16 to C-18; (Healthy People 2020, 2011). Because of these objectives and other public
health goals, behavioral scientists have focused on investigating pathways to behavioral
change in oncological services. One important thesis is of the extent of an individual’s
perceived capability to perform behaviors related to cancer screenings. As discussed
earlier, self-efficacy has been shown to positively impact health outcomes, thus
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mechanisms related to increase cancer screening behaviors, including self-efficacy, are of
great importance in the field of behavioral oncology.
Many researchers have measured self-efficacy related to performing cancerrelated skills through single-item or very short assessments in a variety of health
behaviors. Bastani and colleagues assessed confidence in performing breast selfexaminations with a single item in a study conducted in California (Bastani, Marcus, &
Hollatz-Brown, 1991); Similarly, Allen and colleagues (1998) assessed, with 2-single
items, the level of confidence of participants in discussing mammography screening with
their health care provider and in maintaining their scheduled mammograms (Allen,
Sorensen, Stoddard, Colditz, & Peterson, 1998). Another study assessed efficacy to
perform breast self-examinations, efficacy to obtain a clinical breast exam, and efficacy
to obtain a mammography with 3 single items (Kurtz, Given, Given, & Kurtz, 1993).
Boehm and colleagues measured confidence in performing prostate-cancer-related tasks
among African American males with a 4-item questionnaire, and results showed that
participants’ self-efficacy scores improved (t= -6.14; p=<.001) after attending an
educational program on prostate cancer (Boehm et al., 1995). Others have assessed
participants’ ability to perform a fecal occult blood test (FOBT) with a single item scored
in a 4-point-likert scale, and results showed that one of the factors related to adherence to
FOB testing was self-efficacy; other factors included demographic characteristics and
having concerns about the disease (Myers et al., 1994).
There are very few validated cancer-related self-efficacy scales. One of the few
studies on cancer screening behavior related to self-efficacy was conducted by Wehrwein
and Eddy (1993). The study was conducted with a small sample of women taking part in
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a clinical breast exam and mammography screening program at a Women’s Center
affiliated with a community hospital. Participants completed a 22-item self-efficacy
questionnaire, developed by Coppel (1980), and other questionnaires about healthpromoting behaviors, lifestyles and locus of control. Researchers found that self-efficacy
was a significant predictor of health promoting behaviors (r= .32; p<.05), and the scale
had a very good internal reliability score of .91, but no other psychometric information
was reported on the scale (Wehrwein & Eddy, 1993). Other studies have assessed selfefficacy related to adjustment and promotion of health with cancer patient populations,
and results showed positive correlations between self-efficacy and quality of life, and
negative correlations with psychological symptoms (Lev & Owen, 1996). Then, more
recently, the validation of two self-efficacy scales were published in the literature. First a
10-item scale to assess self-efficacy of mammography screening was developed in 2005
(Champion, Skinner, & Menon, 2005). Psychometric examinations revealed that the
measure had good internal consistency (α=.87) and moderately acceptable test-retest
reliability (r=.52, p <.001). Furthermore, the study findings indicate that higher selfefficacy scores increased the likelihood that participants would receive a mammogram,
specifically, for every point increment in the self-efficacy scale, a woman was 1.09 times
more likely to get a mammogram (OR=1.09, 99% CI, 1.06 to 1.22); physicians’
recommendation and income were also related to higher likelihood of receiving
mammograms (OR=1.77; 99% CI, 1.13 to 2.76, and OR=2.07; 99% CI, 1.51 to 2.84,
respectively). A second relatively recent study developed an instrument to examine
cervical cancer screening self-efficacy among low-income Mexican American women.
The final scale was comprised of 8 items with high internal consistency (α=.95). Content
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validity was evaluated for content relevancy, and the instrument was translated into
Spanish using “universal broadcast Spanish” (Fernandez et al., 2009). Study results
showed that women with higher self-efficacy were more likely to have had a recent Pap
test than those with lower self-efficacy scores. Even though the psychometric properties
and overall characteristics of this instrument look promising for a clinical application, it
is hard to generalize their findings to other populations, since the study’s target
population was women of Mexican origin living in southern Texas and California.
The evidence presented above exemplifies how perceived self-efficacy helps
investigators understand how psychological pathways contribute to behavior modification
when it comes to cancer-related behaviors, including cancer screenings.

These

mechanisms should be further explored and their clinical and practical value should be
emphasized amongst practitioners who can counsel their patients by providing them
feedback that would enhance patients’ knowledge and enhance skills that would enable
patients to become more efficacious about getting the health care they need. This is also
a potential area of study for intervention programs aiming to promote early detection and
prevention of cancer.
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THEORETICAL FRAMEWORK

This study used the social cognitive theory as a theoretical framework. The social
cognitive theory, developed by Albert Bandura in 1962, was derived from previous
explorations of human behavior; Bandura further added to these explorations the concept
of social learning. From this theoretical perspective, human behavior is the product of the
interaction of social, environmental, and personal factors. The product of this interaction
involves the influence of people’s thoughts and actions; human beliefs and cognitive
competencies which are the products of social influences and structures within
environments; and, behaviors that determine aspects of the environments. According to
this theory, cognition plays a critical role in an individual’s capability to make sense of
reality, self-regulate, assimilate information, and most importantly, perform a behavior.
This theory helps explain the pathways by which human behavior is influenced by
environmental outcomes, and by an individual’s cognitive processes and interpretation of
outcomes. According to Bandura (1986), “a theory that denies that thoughts can regulate
actions does not lend itself readily to the explanation of complex human behaviors.”
(Bandura, 1986) Social cognitive theory poses a view of human capacity in which
individuals are actively involved in their own development and can make things happen
through their own actions. In other words, “what people think, believe, and feel affects
how they behave” (Bandura, 1986).
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Hence, the beliefs that individuals hold about themselves are fundamental in the
exercise of control and personal capacity. These beliefs are also important in collective
capacity, which makes this theory applicable to human adaptation and change in
collectivistic societies, as it is largely the target population of this study.
Social cognitive theory posits that socio economic factors, such as economic
status, educational attainment, and familial structures, may influence self-efficacy beliefs
indirectly. Furthermore, knowledge and skills influence individual’s behavior, but only to
a certain level; often times not enough to achieve the desired behavioral change. As
Bandura (1997) states, “people’s levels of motivation, affective state, and actions are
based more on what they believe than what is objectively true” (Bandura, 1997). Thus,
behavior often can be better predicted by people’s beliefs on what they can achieve than
what they actually know or are capable of accomplishing.

PERSON

BEHAVIOR
Efficacy
Expectations

OUTCOME
Outcome
Expectations

Figure 1. Theoretical model
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AIMS

There is a dearth of validated measures to assess the perceived ability to obtain the
recommended care after an abnormal cancer screening. To the authors’ knowledge, no
validated measure assessing self-efficacy following a cancer abnormality under a number
of barriers to care has been published.
For this reason, this study aims to:
1. Evaluate content validity of the measure using a panel of experts.
2. Conduct an Exploratory Factor analysis to explore the instrument’s internal
structure.
3. Assess the internal consistency reliability of the measure.
4. Examine convergent and discriminant validity.
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HYPOTHESES

On the basis of earlier research documented in the literature, the following hypotheses
were formulated:
1. Factor Analysis will yield at least one factor.

2. The self-efficacy instrument will be found to be a reliable measure of self-efficacy
as will be demonstrated by a Cronbach’s alpha coefficient of .70 or greater.

3. The self-efficacy instrument will be positively correlated with theoreticallyrelated variables (convergent validity) as follows:
a. Outcome Expectations: Positive correlation coefficients (> 0.30) will be
found between self-efficacy scale and cancer response scales (breast and
colorectal),
b. Perceptions of Control: Positive correlation coefficients (>.30) will be
found between self-efficacy scale and Personal Mastery Scale.

4. The self-efficacy instrument will be weakly, negatively correlated with a
theoretically-related variable (discriminant validity): Depression. Correlation
coefficients (<.0) will be found between self-efficacy and depression.
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METHODS
Overview
The purpose of the study was to describe the development and psychometric
evaluation of a measure of self-efficacy for obtaining follow-up care following an
abnormality suspicious for cancer. To do this, the study utilized a multi-step process to
reduce the original pool of items (item refinement phase I) and obtain evidence of
validity and reliability (item refinement phase II; see figure 2). Further details are
explained in the sections below.

Figure 2. Overview of study
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DEVELOPMENT OF THE SELF-EFFICACY MEASURE

The self-efficacy measure utilized in this study was developed by investigators of
a patient navigator research project (PNRP) of the Moffitt Cancer Center site. The PNRP
is a federally-funded research project aimed at reducing cancer health disparities by
eliminating barriers to access to care through the provision of culturally-appropriate
services of a Patient Navigator (Freund et al., 2008; Wells et al., 2008). Patient navigators
were lay individuals from the community who were trained to provide services and health
resources to patients, and navigate them through the health care system in a timely
manner (Wells et al., 2011). The PNRP-Moffitt was part of a nation-wide, multi-site
program funded by the National Cancer Institute through the Patient Navigator Outreach
and Chronic Disease Prevention Act in 2005.
Guided by Bandura’s social cognitive theory, and with medically underserved
populations in mind, a team of PNRP-Moffitt investigators developed a self-efficacy
instrument to assess participant’s confidence in their ability to acquire needed follow-up
care under various circumstances after having an abnormal cancer screening. Several
items were generated to reflect multiple steps associated with obtaining follow up care,
including potential instrumental, logistic and belief barriers that may play a role in
preventing help-seeking behaviors. The original instrument was comprised of 51 items,
most of which start with “I can…”; some items ask about the participant’s perceived
ability in getting follow-up care even if encountered with barriers, and other items ask
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about the participant’s perceived ability to overcome barriers proactively or by seeking
someone else’s help. The response scale of this instrument consists of a 5-point Likertlike scale (Strongly agree, Agree, Neutral, Disagree, and Strongly disagree; see appendix
I for English version and appendix J for Spanish version). An initial draft of the measure
was tested with a small sample of community participants using cognitive interviews.
The cognitive interviews helped identify semantic and grammatical issues, language
idiosyncrasies and overall participants’ comprehension of the items. Items were refined
based on feedback obtained from these cognitive interviews.
Subsequently, the instrument was pilot tested with a sample of baseline
participants (n=106) from the PNRP-Moffitt project, and these data was utilized to
answer the research questions of this project. Pilot test data collection is described in the
following sections.

Pilot Test Study Design & Sample
Using a cross-sectional study design, the PNRP project collected psychosocial
data to assess study aims at baseline (following an abnormality suspicious for cancer), at
resolution (after receiving follow-up care that may or may not result in a diagnosis of
cancer), and during treatment (for those patients diagnosed with cancer). Self-efficacy
data were only collected at one administration point: following the discovery of a
symptom or screening abnormality for breast or colorectal cancer (i.e. baseline). Onehundred and six participants participated in the pilot test of the self-efficacy measure. The
sample composition was as follows: 78% completed the instrument in Spanish (n=83)
and 22% completed the instrument in English (n=23). The large majority of respondents
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were enrolled for breast abnormalities (n=92), and 13% for colorectal abnormalities
(n=14).
Study Setting & Population: The pilot study was conducted at Moffitt Cancer
Center, located in Tampa, FL. The PNRP participants were recruited from federally
qualified health centers and hospitals within four counties of Central West Florida:
Hillsborough, Pinellas, Pasco, and Manatee. The population of Central West Florida is
highly diverse.
First, Hillsborough has an estimated adult population of 772,255 people, and
approximately 15% of its population is foreign born. It is estimated that 12% of its
population is over 65 years. Furthermore, it is estimated that 9.6% of families in this
county live below the poverty levels (US Census Bureau, 2006-2008). As to diversity,
while Caucasian race is the most prominent race of all, there are several minority
communities in the county, African-Americans and Hispanics being the largest (16% and
22%, respectively).
Pasco county’s population is estimated at 417,028 people, 7% of which are
foreign born. Languages other than English are spoken in 10.3% of the households.
77.6% of it population are high school graduates. Twenty-one percent of its population is
over the age of 65 (US Census Bureau, 2006-2008). Although the majority of the
population is Caucasian (90.3%), this county has a large farm working population.
Pinellas County is the second smallest county in Florida. Nevertheless, it is
considered the most densely populated in the state (Pinellas County Government, 2006).
Its population was estimated at 910,260 people in 2008. A small segment (9.5%) of its
population is foreign born, and in 12% of its households, languages other than English

21

are spoken. Pinellas has a substantial percentage of African Americans (10%), about 7%
of Hispanics, and approximately 3% of Asians. Twenty percent of people in this county
are over the age of 65 (US Census Bureau, 2006-2008).
Manatee County’s estimated population in 2008 was 315,766 people. Eight
percent of its population is foreign born, and languages other than English are spoken in
12.3% of its households. Twenty-two percent of the population is 65 years or older (US
Census Bureau, 2006-2008).

Pilot Data Collection
Participants: Participants were referred to the PNRP by health care providers of
the 12 participating community health clinics. Patients presenting with an abnormal
screening test or physical finding for breast or colorectal cancer were eligible to
participate if they received care at the participating health center and were 18 years of age
or older. Patients newly diagnosed with breast or colorectal cancer were eligible to
participate if they had not undergone cancer treatment. In addition, patients diagnosed
with cancer within five years of the referral, or patients with previous history of other
cancers, except non-melanoma skin cancer, were ineligible to participate in the PNRP
study. Once enrolled in the main program, all participants were eligible to participate in a
survey to assess psychosocial outcomes of patient navigation. Participants were contacted
at baseline.
Measures & Materials: Participant demographic information was collected in
person from study participants using a demographics questionnaire with items regarding
participants’ race, ethnicity, education, marital status, nationality, native language,
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language preference, housing, employment and insurance status. The demographic
questionnaire was professionally translated into Spanish (see Appendix A for English
version and Appendix B for Spanish version-demographics). In addition, participants
were administered a battery of 14 instruments including:



A Cancer Response Efficacy Scale (see Appendices C & D), which measures
outcome expectations related to a) breast and b) colorectal cancer. The scale is
comprised by 4-5 items, and it is answered in a 5-point Likert-like scale (Strongly
Agree to Strongly Disagree). Outcome expectations is conceptually defined as
judgments of the consequences that a) having a mammogram or b) having a
colorectal cancer screening will produce. In the study, lower scores reflect better
(+) outcome expectations, possible scores for the 5-item breast response efficacy
scale are 1-25, and scores for the 4-item colorectal cancer response efficacy scale
are 1-20.



The Personal Mastery Scale (Pearlin & Schooler, 1978), measures perceptions of
control, which is conceptually defined as the extent to which a person perceives
circumstances as being under his/her own control. This scale consists of 7 items
and it is answered in a 5-point Likert scale (Strongly Agree to Strongly Disagree).
The scale has previously shown moderate test-retest reliability (.44) and construct
validity (Pearlin, Menaghan, Morton, & Mullan, 1981); Scoring for this scale
ranges from 1 to 35. In the study, some items in the scale were reverse coded, so
lower scores reflect higher perceptions of control.
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The Patient Health Questionnaire (PHQ) depression module #9, which is a brief
9-item instrument to assess depression according to DSM-IV criteria, answered
from “Not at all” to “Nearly Every Day.” The PHQ-9 is a reliable and valid
measure of depression severity (α=.89) (Kroenke, Spitzer, & Williams, 2001); In
this study, higher scores reflect more depression symptoms, and scores can range
from 1 up to 36 (see appendix G for English version and appendix H for Spanish
version).



A self-efficacy instrument, consisting of 51 items in a 5-point Likert-like scale
(Strongly agree, Agree, Neutral, Disagree, and Strongly disagree). In this study,
lower scores in the scale mean that participants have high confidence in their
ability to obtain follow-up care after having a cancer abnormality. Scores can
range from 1 to 255 (see Appendix I for English version and Appendix J for
Spanish version).

Procedures: Upon enrollment, i.e. after subjects had agreed to participate and
signed an informed consent to participate in the PNRP, participants were contacted over
the phone to take part in a 60-minute in-person interview including the administration of
all the other tools. The interviews were conducted by three research assistants (RAs), in
English or Spanish. Survey participants were administered a battery of 14 instruments
during the interviews at baseline. For the majority of participants, instruments were read
to them in their totality, and response cards, in English or Spanish, were used to assist
participants with remembering the response scales. The instruments that were not readily
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available in Spanish were translated by a certified professional translator and
backtranslated by a member of the PNRP staff.

Data Management
Hard copies of survey data were stored in locked cabinets at Moffitt Cancer
Center. Participants’ identity and confidentiality were protected by assigning a participant
ID that was a combination of numbers created by the PNRP. Electronic data were stored
in databases that were located in secured network folders restricted to research personnel
only. The databases were backed up daily, and data accuracy was confirmed with testing
a small sample of entries.
All research personnel received training on research involving human subjects
and HIPPA regulations.
Survey data were entered in a password-secured Access database, and 10% of
data were checked randomly for accuracy of data entry.
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DATA EXAMINATION

The first step of this study, as shown in figure 2, was to conduct a preliminary
examination of the data collected in the pilot test phase. Data were examined using
descriptive statistics generated using the Statistical Package for the Social Sciences,
version 20 (SPSS, 2011).
First, a descriptive table of the sample, containing frequencies, variance, etc., was
generated using all 51 items in the scale. Variables with high non-completion rates (i.e.
variables containing more than 5% of missing data) were discarded. Variability of
responses was examined by looking at measures of data dispersion, and items with low
variability (i.e. items with standard deviation of less than .75) were eliminated. Low
dispersion indicates that responses were not spread out across response options 1-5. Noncompletion rates and low variability of responses may be indicative of items that are hard
to answer or not relevant to participants. This data reduction strategy was performed to
facilitate other steps in the development of the instrument. Overall, the goal of this
project was to identify the best possible items to include in a self-efficacy scale for
obtaining follow-up care after a cancer abnormality.
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CONTENT VALIDITY ASSESSMENT

In order to further examine psychometrics of the self-efficacy measure, the study
conducted content validity assessments using a panel of experts identified purposively
based on their knowledge and expertise regarding self-efficacy.
The goal of assessing content validity is to determine whether items in an
instrument are in fact relevant to the construct of interest, and also to assess if all areas of
interest under this construct are covered by the instrument (Brod, Tesler, & Christensen,
2009). There is a debate in the literature as to whether or not content validity should be
used in instrument psychometric assessment because some investigators believe that
“content validity deals with inferences about test construction; construct validity involves
inferences about test scores. Since by definition all validity is the accuracy of inferences
about test scores…content validity is not validity at all” as cited in (Beckstead, 2009), p.
1276). Others propose that inter-rater agreement is the best procedure for calculating
content validity, as it represents the extent to which raters make exact judgments about
items. Despite this, multiple researchers utilize content validity assessments in their scale
constructions as it provides information about the item clarity, representativeness and
relevance to the construct, and it also provides valuable feedback for improving the
measure by evaluating each item in the scale (Chung, Wong, & Griffiths, 2007; May &
Limandri, 2004; Rubio, Berg-Weger, Tebb, Lee, & Rauch, 2003; Schilling et al., 2007;
Zimmaro Bliss, Dhamani, Savik, & Kirk, 2003). Based on the review of the literature and
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having considered the divergent points of view regarding content validity, this project
conducted an examination of the content validity because it provided a valuable
assessment of the items’ content and relevance to a construct (e.g. self-efficacy). In
addition to rating relevancy, reviewers were asked to assess item’s clarity, redundancy,
and they were asked to provide recommendations related to refinement of wording and
content domain of items.
Previous studies on content validity have revealed that the number of experts may
vary between 2 and 20. Many of the studies recommend that at least 3 experts review
measures of the size of the measure in this study (Polit & Beck, 2006). Recommendations
for forming a panel of experts include: selecting experts that are well versed in the
subject of interest and who have instrument development expertise (Davis, 1992;
Schilling, et al., 2007).

Content Validity Assessment Methods
Sample: Snowball sampling was utilized to identify content validity reviewers.
According to inclusion criteria reviewers had to: a) be professionals with varying levels
of health care experience, b) have theoretical and practical understanding of the
conceptual framework underlying the instrument i.e. self-efficacy, c) have instrument
development expertise, and d) be able to read, write and speak fluent English and/or
Spanish language. Any individual involved in the development of the original instrument
was excluded and could not serve as a content validity reviewer.
Participants: A sample of reviewers (n=12) were identified based on the criteria
described above. After reviewers were identified, each of them received an email
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soliciting their assistance and participation in this project (see Appendix K). No monetary
incentives were provided to the reviewers; however, reviewers were offered a copy of the
final instrument as an incentive to participate. Seven content validity assessments were
conducted in English, and five assessments were conducted in Spanish language (see
results for further details).
Materials: Experts were asked to rate each instrument item using a content
validity rating form in either English or Spanish, depending on their language preference
(see Appendix L). The rating form explained in detail how to complete the assessment,
provided an overview of the instrument, described the domains to be rated (i.e. relevance,
clarity, and redundancy), and provided a definition of the domain under assessment (i.e.
self-efficacy). Reviewers were asked to rate each item as “Relevant” “Somewhat
relevant” “Slightly relevant” and “Not relevant at all,” as this is a recommended method
to assess variability of rating amongst reviewers (Polit & Beck, 2006). In addition,
reviewers were asked to provide feedback on the items’ clarity (e.g. “item is not clear”,
“item needs major revisions”, “item needs minor revisions”, “item is clear”). Lastly,
reviewers were asked to provide comments for each item (e.g. related to item
redundancy, or linguistic and cultural acceptability of items). Each of these steps aided
decisions regarding item retention and deletion. The rating form utilized for the study is a
modified version of the content validity rating form described in another study (Rubio, et
al., 2003).
Procedures: Experts were contacted by electronic, telephonic or personal
communications. An initial invitation was mailed or emailed to potential reviewers, and
additional reviewers were referred by other reviewers in a snowball technique. Reviewers
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who agreed to participate were sent a rating form, described above. Reviewers were
asked to complete the rating form and send it back electronically or by mail. The
assessment form was estimated to take 20 minutes to complete. Five of the assessments
were conducted in Spanish language in order to assess the content validity of the Spanishlanguage items, using the same methodology as the English-language content validity
assessments (See Appendix L).
Data Management: Answers were de-identified and recorded on a score sheet and
then entered on a spreadsheet for record keeping. No other data from the reviewers were
collected, and no data were linked to their names or any other personal identifier. All
study data were stored in a password-protected computer.
Analysis: Reviewer agreement was assessed manually using a multi-rater method
to calculate the item-by-item content validity index as discussed in Polit & Beck (2006).
First, ratings are examined and subsequently collapsed into dichotomous variables. Then,
item-by-item calculations were performed by identifying the items that had relevancy (of
relevant or somewhat relevant) ratings across all raters. Rating procedures are further
explained in the results section. Judgments on the retention of items were evaluated upon
receipt of all ratings. Generally, studies only retain items with scores of 80% agreement
or higher, across raters (Davis, 1992; Selby-Harrington, Mehta, Jutsum, RiportellaMuller, & Quade, 1994); However, based on practical knowledge and recommendations
from committee members, this study retained items with 60% or higher agreement across
raters. Ratings were examined independently by language (English or Spanish). Lastly,
ratings on clarity were tallied and qualitative responses were compiled in a separate table.
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PSYCHOMETRIC EVALUATION
Psychometric evaluation of newly-developed instruments is pivotal in behavioral
measurement. Researchers have an essential need to evaluate, examine, and assess
different behaviors; hence, a good gauging mechanism is needed. As a result, several
systematic methods have been developed to explore the properties and characteristics of
instruments. The following section describes the methods that were utilized to evaluate
psychometric properties of the self-efficacy measure for obtaining cancer-related followup care after an abnormality suspicious for cancer.
Data were analyzed using Statistical Package for the Social Sciences (SPSS Inc.,
2011). Descriptive statistics were used to summarize demographic information about
participants. Inferential statistics were conducted to assess the psychometric properties of
the scale and to test the study hypotheses. Data cleaning measures were taken prior to the
analysis of data.

Factor Analysis
An Exploratory Factor Analysis (EFA) was conducted to identify underlying
factors of the instrument. An EFA is commonly utilized to a) determine a set of common
factors influencing a construct in an instrument, b) identify a set of items that could be
group together to form a factor, and c) gauge the strength of the relationship between a
factor and each item that fall within it (DeCoster, 1998; Nunnaly & Bernstein, 1994).
Costello and Osborne (2005) conducted a review of studies reporting usage of EFA in
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scale development, and while the majority (62.9%) of the studies utilized a 10:1 (subject
to item) ratio, 15% of the studies reported having conducted factor analyses of 2:1 or less
ratios. It is also important to note that their analyses of the effects of subject-to-item
ratios on EFA’s specificity concluded that utilizing larger samples can yield more
accurate EFA results (Costello & Osborne, 2005).
In this study, an EFA was utilized to examine possible underlying factors within
the SE measure that was previously developed. The initial pool of items (i=51) was
significantly reduced, from 51 items to 13 items, after the item reduction strategies
utilized in the previous item refinement section. Consequently, the study utilized a
moderate subject to item ratio (8:1) to construct an EFA.
Methods of Analysis: Maximum likelihood was the procedure chosen to fit the
Common factor model in the EFA conducted. Frabrigar and colleagues (1999)
recommend this fit for data that do not violate the normality assumption ( skew < 2;
kurtosis < 7; Fabrigar, Wegener, MacCallum, & Strahan, 1999). The number of factors
retained was determined by a visual examination of a scree plot. This graphical
representation of eigenvalues was examined, and the number of eigenvalues that occured
before plateau was the number of retained factors. The study utilized an oblique rotation
method (direct oblimim) as there were some correlations among the factors.

Reliability Analysis
The scale reliability was assessed by calculating internal consistency reliability
(cronbach’s alpha). Internal consistency is an assessment of the homogeneity of the items
that comprise the scale (Ferketich, 1991). Linkages between the items exist, and the
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assessment of the instrument’s reliability allowed linkages between items and the latent
construct to emerge. A scale is internally consistent if its items are highly intercorrelated. High-item inter-correlations may suggest that the items are all measuring the
underlying construct. Assumptions can be made that correlations between items reflect
strong links between items in the scale and the underlying domain. In addition, item-tototal scores reflect the impact of a given item on the entire scale, especially if the item is
deleted.

Validity Analysis
A correlation matrix was constructed to examine the relationship between selfefficacy and other study variables (outcome expectations, perceptions of control, and
depression). To assess convergent and discriminant validity, patterns of inter-correlations
between the two measures were examined. Pearson’s product moment correlation
coefficients between theoretically-related measures should be high (convergent), while
correlations between theoretically unrelated measures should be low (discriminant). It
was hypothesized that outcome expectations and perceptions of control would be highly
correlated with self-efficacy, to provide evidence of convergent validity. Whereas, low
correlations between depression and self-efficacy would provide evidence of discriminant
validity, as theoretically, they should differ.
In terms of convergent validity, relationships between SE and perceptions of
control were assessed, as there is documented evidence of a positive association between
these two constructs (Bandura, 1977; Grecas, 1989). Although these two constructs are
distinct, such as self-efficacy expectations have to do with the person’s ability to perform
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a certain behavior, and perceptions of control, aka personal mastery, is the extent to
which a person believes that an outcome is controllable (Bandura, 1977). These two
constructs can influence behavioral outcomes by taking into consideration personal
capabilities (e.g. a person’s confidence in getting screened) and controllable outcomes
(e.g. beliefs of personal control over one’s health screening behaviors).
Similarly, outcome expectations are “judgments of the likely consequences a
behavior will produce” (p. 438), in other words, outcomes expectations are an
individual’s beliefs of whether a behavior will lead to a certain (positive or negative)
outcome (O'Leary, 1985). Outcome expectations are also closely related to perceived
self-efficacy, and both have shown predictive values of intention to engage in a behavior.
Although outcome expectations and self-efficacy are two different constructs, Bandura
proposed an inter-relational nature of these two constructs due to the influence of
outcomes expectations on beliefs of self-efficacy. For instance, if an individual lacks
confidence to perform a behavior, balancing benefits and consequences of such behavior
will not be powerful enough to perform the behavior. Likewise, feelings of perceived
inefficacy can nullify any positive outcome expectations about such behavior (Schwarzer
& Reinhard, 1995).
To

assess

discriminant

validity,

the

relationship

between

depression

symptomatology and self-efficacy will be examined. Theoretically, these two constructs
are distinct, as self-efficacy differs from depression in that latter is a mental disorder that
disrupts a person’s social functioning and interferes with well-being, whereas selfefficacy has to do with a person’s perceived ability to perform a desired behavior.
Depression is accompanied by feelings of hopelessness, negativism and low sense of
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personal agency. It was hypothesized that these two measures would correlate negatively
and have a low correlation coefficient; meaning that a person with higher depression
scores (as measured by the PHQ-09) might exhibit lower Self-efficacy scores. In order to
gather evidence of discriminant validity, the strength, rather than the direction of the
association was examined. Depression and self-efficacy might correlate negatively
because of their theoretical association; however, in order in terms of validity, their weak
association provides evidence of the distinction between these two constructs.
Furthermore, gathering sufficient evidence of theoretically-related constructs and
theoretically-unrelated constructs between measures is one way of calculating construct
validity (Nunnaly & Bernstein, 1994; Rubio, et al., 2003).
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RESULTS
Data Examination Results
The first step of this study was to examine the composition and quality of
variables contained in the self-efficacy measure. Descriptive statistics were utilized to
generate a snapshot of the 51 self-efficacy items. Variability and completion rates were
examined as a data reduction strategy. Items were eliminated based on two criteria: a)
low variability rates (sd < 0.75), and b) low completion rates (more than 5% of missing
data at the variable level). Table 1 provides a summary of variables deleted and variables
retained for additional analyses.
As seen in table 1, a total of 38 variables were eliminated based on these criteria.
The majority of these variables were found to have low variability. Low variability
indicates that responses were not spread out across response options (i.e. strongly agree
to strongly disagree). These items may have been difficult to understand or simply not
relevant to participants in the sample. For this reason, it is important to eliminate these
items in early stages of data analysis. A smaller number of variables, 7 out of 38, were
eliminated due to a significant percentage of missing data (>5%). Lack of responses also
may be indicative of problematic items which participants may have found hard to
answer or not relevant.
The remaining items (13), as summarized in table 2, were found to meet the
inclusion criteria. Thus, these items were retained.
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Table 1. Deleted items based on variability and completion rate criteria (items=38)

Item
bse1
bse4
bse5
bse6
bse7
bse8
bse9
bse10
bse11
bse12
bse14
bse15
bse17
bse18
bse19
bse20
bse21
bse22
bse23
bse24
bse25
bse26
bse28
bse29
bse30
bse31
bse32
bse33

Standard
deviation
(< .75)

Missing
data (>
5%)

Reason for deletion

.749
Low variability
.607
Low variability
.651 39 (36.7%) Missing data
.506
Low variability
.539
Low variability
.537
Low variability
.705 11 (10.3%) Missing data
.730
Low variability
.675
Low variability
.489
Low variability
.710
Low variability
.697
Low variability
.680 38(35.8%) Missing data
.736
9 (8%) Missing data
.639
Low variability
.571
Low variability
.583
Low variability
Low variability/
.553
7 (6%)
missing data
.533
Low variability
.533
Low variability
.472
Low variability
.676
Low variability
.601 44 (41.5%) Missing data
.576
Low variability
.472
Low variability
.628
Low variability
.697
Low variability
.628
Low variability
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Table1. (Continued)

Item
bse34
bse35
bse36
bse37
bse38
bse39
bse40
bse43
bse48
bse50

Standard
Missing
deviation
data (>
(< .75)
5%)
.487
.625 43 (40.5%)
.518
.667
.549
.626
.520
.692
.720
.564

Reason for deletion
Low variability
Missing data
Low variability
Low variability
Low variability
Low variability
Low variability
Low variability
Low variability
Low variability

Table 2. Items retained after data examination analysis (i=13)

Item
bse2
bse3
bse13
bse16
bse27
bse41
bse42
bse44
bse45
bse46
bse47
bse49
bse51

Standard
deviation
1.195
.782
.779
.782
.789
.763
.763
1.045
.950
1.054
.880
.770
.859

38

Missing
data
(> 5%)

Content Validity Analysis Results
The next step of the development of this instrument was to assess content validity
(CV) to determine content relevance of the items, thus assessing the extent to which the
instrument was indeed a measure of self-efficacy for obtaining follow up care following
an abnormality suspicious for cancer. Item clarity was also examined in this step.
Sample Composition: A total of fourteen investigators were contacted and asked
to participate in the content validity assessment of this instrument. Seven researchers
were contacted to review English-language items, and the other seven were contacted to
review Spanish-language items. All seven English-speaking individuals who were asked
to provide CV ratings agreed to take part and completed the rating form. These Englishlanguage reviewers were a post-doctoral trainee (n=1) and professors (n=6) at academic
and non-profit health institutions in the states of Florida, Georgia, and Maryland. Five out
of seven Spanish-speaking researchers who were asked to take part in the study agreed to
review and rate the items. Their professional training ranged from a doctoral student
(n=1) to post-doctoral trainees (n=2) to academic professors (n=2) at educational
institutions in Florida, California, and Texas. One person declined participation due to
time constraints, and one person did not respond.
Interpretation of Content Validity ratings: The study calculated a content validity
index at the item level and at a scale level, as described by Polit 2006. The item content
validity index (I-CVI) is an index of agreement among reviewers and it was calculated
by, first, dichotomizing ratings (of quite relevant and highly relevant as “relevant -1-”,
and ratings of not relevant and somewhat relevant into “not relevant -0-”), and then
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calculating the average of “relevant -1-“ ratings across all reviewers. For example, in
Table 3, six out of seven reviewers rated item2 as relevant. Thus, the I-CVI equals 0.86,
whereas item3 was rated as relevant by all 7 reviewers, hence its I-CVI equal 1.00. The
mean I-CVI was calculated by summing all I-CVIs and dividing by the number of items.
The Scale Content Validity Index (S-CVI) is the proportion of items in the scale
given a rating of “relevant -1-” by all reviewers. For instance, the last column in table 3,
labeled “rated relevant by all,” indicates that eight out of thirteen items were rated as
relevant by all experts. Therefore, the S-CVI/UA equals 0.62 (i.e. 8/13). The Mean
Expert Proportion, which is an average of the proportion of items rated as relevant across
reviewers, is also reported in the table. To calculate this, first, individual reviewers’
ratings have to be averaged (e.g. reviewer1 rated relevant 12 out of 13 items, average
ratings for reviewer1 =.92; reviewer2 rated 11 out of 13 items as relevant, average ratings
for reviewer2 = .85, and so forth), then reviewers’ average ratings are combined and
divided by the number of reviewers in the sample (a second average calculation). The
mean expert proportion always equals the mean I-CVI (0.95), as seen in table 3.
There are important distinctions between I-CVI and S-CVI, as described above,
and Polit (2006) recommends to not only report both index scores, but also to provide an
explanation on how these indexes were generated.
Content Validity Results: For the English-language items (i=13) the I-CVIs
ranged from 0.86 to 1.00 (mean I-CVI = 0.92; as seen in table 3), and for Spanishlanguage items I-CVI ratings ranged from 0.60 to 1.00 (mean I-CVI = 0.92; as seen in
table 4). The English-language instrument had a S-CVI value of 0.62, whereas the
Spanish-language instrument had a S-CVI value of 0.69.
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Content validity assessments were utilized as a second step in the instrument
development process. Retention criterion was set to I-CVI = 0.60, which is more liberal
than the acceptable standard of .80. As summarized in tables 3 and 4, all English and
Spanish items met the retention criteria. To explore relationships among these variables, a
correlation matrix was generated (see table 5). Table 5 indicate that there are some smallto-moderate correlations between the items, except for items 42 and 27, which are highly
correlated (r=.723).
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Table 3. Content Validity Ratings - English-language Items

Content Validity Reviewers
Item #
2
3
13
16
27
41
42
44
45
46
47
49
51

Reviewer Reviewer Reviewer Reviewer Reviewer Reviewer Reviewer
1
2
3
4
5
6
7
1
1
0
1
1
1
1
1
1
1
1
1
1
0.92

0
1
1
1
1
1
1
0
1
1
1
1
1
0.85

1
1
1
1
1
1
1
1
1
1
1
1
1
1.00

1
1
1
1
1
1
1
1
1
1
0
1
1
0.92

1
1
1
1
1
1
1
1
1
1
1
na
1
0.92

†

1
1
1
1
1
1
1
1
1
1
1
1
1
1.00

1
1
1
1
1
1
1
1
1
1
1
1
1
1.00

6
7
6
7
7
7
7
6
7
7
6
6
7

0.86
1.00
0.86
1.00
1.00
1.00
1.00
0.86
1.00
1.00
0.86
0.86
1.00

MEAN I-CVI †=
S-CVI/UA ††=
Mean expert proportion

0.95
0.62
0.95

I-CVI, item-level content validity index.
S-CVI/UA, Scale-level content validity index, universal agreement calculation method.
(Polit & Talano Beck, 2006)
††
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Rated
Item relevant
CVI by All

Number in
Agreement

1
1
1
1
1
1
1

1
8

Table 4. Content Validity Ratings - Spanish-language Items

Content Validity Reviewers
Item #

Reviewer
1

Reviewer
2

Reviewer
3

Reviewer
4

Reviewer
5

1
1
1
1
1
1
1
1
1
1
1
1
1
1.00

1
1
1
1
1
1
1
1
1
1
0
0
1
0.85

1
1
1
1
1
1
1
1
1
1
1
1
1
1.00

1
1
1
1
1
1
1
1
1
1
1
1
1
1.00

1
1
0
1
1
1
1
0
1
1
1
0
1
0.77

2
3
13
16
27
41
42
44
45
46
47
49
51

†

Number in
Agreement
5
5
4
5
5
5
5
4
5
5
4
3
5

MEAN I-CVI † =
S-CVI/UA †† =
Mean expert proportion

I-CVI, item-level content validity index.
S-CVI/UA, Scale-level content validity index, universal agreement calculation method.
(Polit & Talano Beck, 2006)
††
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Item
CVI
1.00
1.00
0.80
1.00
1.00
1.00
1.00
0.80
1.00
1.00
0.80
0.60
1.00
0.92
0.69
0.92

Rated relevant
by All
1
1
1
1
1
1
1
1

1
9

Table 5. Inter-item correlations

bse2
bse3
bse13
bse16
bse27
bse41
bse42
bse44
bse45
bse46
bse47
bse49
bse51

bse2
1
.292**
.315**
.215*
.155
.063
.242*
.087
.218*
.188
.273**
.205*
.196*

bse3

bse13

bse16

bse27

bse41

bse42

bse44

bse45

bse46

bse47

bse49

bse51

1
.133
.281**
.560**
.295**
.488**
.161
.314**
.085
.120
.357**
.316**

1
.363**
.210*
.396**
.251**
.291**
.469**
.343**
.480**
.074
.469**

1
.337**
.160
.301**
.333**
.500**
.269**
.315**
.418**
.209*

1
.421**
.723**
.271**
.263**
.288**
.246*
.481**
.302**

1
.290**
.326**
.304**
.344**
.317**
.157
.493**

1
.254**
.397**
.308**
.360**
.468**
.390**

1
.352**
.694**
.391**
.153
.410**

1
.450**
.457**
.358**
.398**

1
.405**
.255**
.343**

1
.332**
.539**

1
.099

1
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Item Clarity Results: Reviewers were also asked to rate each item’s clarity
(Appendix L). Table 6 and table 7 summarize clarity ratings by the number of reviewers
who rated each item as item is clear, item needs minor revisions to be clear, item needs
major revisions to be clear, or item is not clear. As seen in Table 6, none of the Englishlanguage items was rated as not clear. At least three, and as high as six, reviewers agreed
that an item was clear. Agreement in terms of revisions ranged from 1 to 4; in other
words, some items had suggestions for revisions by all 4 reviewers, whereas for other
items, only one reviewer suggested revisions for an item.
Clarity ratings for the Spanish-language instrument are markedly different from
the English ratings. Unlike the English-language items, three items were rated as not
clear by three independent reviewers (although data in table 7 is not displayed by
reviewer). Also, a larger number of revisions were suggested by reviewers for the
Spanish-language items.
Qualitative data gathered from reviewers, from the comment section, can be
found in Appendix N. Suggestions for revisions ranged from wording modifications to
cultural nuances in language to recommendations for item deletion based on redundancy
or repetition. These recommendations were especially helpful for the final stages of the
development of this instrument, as some items were slightly modified based on
reviewers’ comments (see later results and discussion section). These comments were
also considered in later stages, when making decisions to eliminate certain items in the
scale as discussed later.
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Table 6. Clarity Ratings by reviewers (n=7) for English-language instrument

Item #
2
3
13
16
27
41
42
44
45
46
47
49
51

Rated as
clear
(n)

Need minor
revisions
(n)

Need major
revisions
(n)

Rated as not
clear
(n)

Suggested
revisions
(n)

3
5
4
3
4
5
5
6
5
6
3
3
5

2
2
1
4
2
1
1
1
2
1
3
3
2

1
0
2
0
1
1
1
0
0
0
1
0
0

0
0
0
0
0
0
0
0
0
0
0
0
0

3
2
3
4
3
2
2
1
2
1
4
3
2

*Each column indicate the number of reviewers who rated item as clear (column 1), item needs
minor revisions (column2), item needs major revisions (column3), or item is not clear (column 4).
Last column indicates the total number of reviewers who suggested revisions to that item (out of
seven reviewers).
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Table 7. Clarity Ratings by reviewers (n=5) for Spanish-language instrument

Item #
2
3
13
16
27
41
42
44
45
46
47
49
51

Rated as
clear
(n)
1
1
0
1
1
3
5
0
1
2
0
1
5

Need minor
revisions
(n)
1
1
1
2
2
0
0
2
1
1
3
2
0

Need major
revisions
(n)
2
2
2
1
1
1
0
1
2
1
1
1
0

Rated as not
clear
(n)
0
0
1
0
0
0
0
1
1
0
0
0
0

Suggested
revisions
(n)
3
3
3
3
3
1
0
3
3
2
4
3
0

*Each column indicate the number of reviewers who rated item as clear (column 1), item needs
minor revisions (column2), item needs major revisions (column3), or item is not clear (column
4). Last column indicates the total number of reviewers who suggested revisions to that item (out
of five reviewers).
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Factor Analysis Results
Thirteen variables were analyzed in an exploratory factor analysis using a
Maximum Likelihood method and an direct oblimin (oblique) rotation. The visual
examination of the scree plot suggested a 4-factor solution (see figure 3), where as
eigenvalues (>1) suggested that only three factors be retained. Each variable that loaded
onto a factor (>0.3) were examined, and based on item characteristics, factors were
interpreted to reflect barriers encountered by participants when trying to obtain
recommended follow-up care. The factors that emerged are as follows: Factor 1 (costs of
care), Factor 2 (transportation), Factor 3 (structural barriers related to health care
system), and Factor 4 (communication). A factor structure matrix and eigenvalues can be
found in tables 8 and 9, respectively. In table 8, it is important to note that item 49
loading in factor 3 showed a negative coefficient (-.123); all other loadings seem fine.
Table 10 displays factor loadings (i.e. coefficients) and percent of variance accounted for
as a result of the factor analysis performed. Most items seemed to load strongly, and there
were only a few items that cross-loaded onto other factors (e.g. 41 [I can get to a health
care appointment even if it is far away], 13 [I can talk to my health care provider even if
I have difficulty understanding him or he], and 49 [I can get follow-up health care even if
I usually use natural remedies to treat disease]). In fact, item 49 cross-loaded across
three factors (2, 3, and 4), yet it did not belong conceptually to any of these factors. For
this reason, item 49 was eliminated and another factor analysis was performed.
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Figure 3. Scree plot for 4-factor solution

Table 8. Factor Structure Matrix for four-factor solution, including item 49

Variable
bse46
bse44
bse27
bse42
bse3
bse49
bse51
bse41
bse45
bse16
bse47
bse13
bse2

Factor 1:
Cost

Factors
Factor 2:
Factor 3:
Transportation Structural

.993
.701
.333
.352
.095
.222
.411
.386
.449
.268
.428
.371
.196

.232
.243
.935
.748
.638
.549
.336
.415
.321
.381
.277
.212
.225
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.254
.356
.154
.237
.170
-.123
.807
.511
.306
.093
.494
.516
.153

Factor 4:
Communication
.421
.360
.383
.518
.369
.547
.422
.266
.733
.652
.590
.517
.392

Table 9. Initial Eigenvalues and total variance explained for by four-factor solution

Factor
1

Initial Eigenvalues
% of
Cumulative
Total Variance
%
4.829
37.148
37.148

Extraction Sums of Squared
Loadings
% of
Cumulative
Total Variance
%
2.513
19.329
19.329

2

1.665

12.804

49.952

2.661

20.467

39.796

2.960

3

1.151

8.852

58.804

1.221

9.394

49.190

1.865

4

1.104

8.494

67.298

.730

5.615

54.805

3.136

5

.816

6.279

73.577

6

.732

5.631

79.209

7

.597

4.596

83.804

8

.520

3.999

87.803

9

.504

3.879

91.682

10
11
12
13

.335
.307
.237
.204

2.573
2.358
1.820
1.567

94.255
96.614
98.433
100.000
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Rotation Sums of Squared
Loadings
Total
2.720

Table 10. Self-efficacy measure items and pattern matrix coefficients for 4-factor solution
Factors
Factor 1:
Cost

Factor 2:
Factor 3:
Transportation Structural

Factor 4:
Communication

Item description

Variable

I can get medicines even if I have trouble
paying for them.

bse44

.633

.034

.111

.044

I can get follow-up health care even if I have
trouble paying for it.

bse46

1.033

-.042

-.119

.031

I can get transportation to health care
appointments even if I cannot drive a car.

bse3

-.156

.606

.095

.127

I can get transportation to health care
appointments even if there is no bus.

bse27

.130

.956

-.016

-.115

I can find people who can help me get to my
clinic appointments.

bse42

.089

.636

.058

.167

I can get to a health care appointment even if it
is far away.

bse41

.180

.337

.414

-.079

I can get follow-up health care even if I get
frustrated with things that go wrong at the
clinic.

bse47

.118

-.024

.332

.462

I can get to a health care appointment that is in
a place I have never been to.

bse51

.051

.140

.729

.140
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Table 10. (continued)

Factor 1:
Factor 2:
Factor 3:
Cost
Transportation Structural

Factor 4:
Communication

Item description

Variable

I can talk to my health care provider even if I have
difficulty understanding him or her.

bse13

.073

-.062

.391

.411

I can talk to my health care provider even if he or
she does not speak my language.

bse2

.017

.049

.046

.349

I can fill out forms at the clinic even if I have trouble
bse16
writing.

.007

.101

-.093

.627

I can get follow-up health care even if I do not
understand the health problem.

bse45

.146

-.044

.082

.670

I can get follow-up health care even if I usually use
natural remedies to treat disease.

bse49

.048

.385

-.317

.431

19.32

20.46

9.39

5.61

% of variance explained by factor

Coefficients greater than 0.30 are bold. Extraction Method: Maximum Likelihood. Rotation Method: Direct Oblimin.
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The visual examination of the scree plot, for the second factor analysis, suggested
a 3-factor solution. The pattern matrix (as seen in table 11) revealed two factors which
were consistent with the previous 4-factor solution: Factor1 (Costs) and Factor 2
(Transportation). However, the third factor was a combination of items which previously
loaded onto the Structural and Communication factors in the initial 4-factor solution.
Item 49 was retained to preserve a meaningful structure of the instrument because the 4factor-solution is easier to interpret in terms of factors. Items loading onto those 4-factors
seem to belong better conceptually than those items loading onto a 3-factor solution.

Table 11. Pattern matrix for 3-factor solution, not including item 49

Variable
bse46
bse44
bse27
bse42
bse3
Bse13
bse51
bse45
Bse16
Bse2
bse41

Factor 1:

Factors
Factor 2:

Factor 3:

1.022
.603
.136
.090
-.145
-.021
.055
-.024
.145
.034
-.001

-.018
.028
.955
.669
.642
-.115
-.063
.061
.019
.176
.071

-.035
.148
-.147
.130
.097
.757
.700
.670
.573
.385
.341

Coefficients >.3 are bold
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Reliability Analysis Results
The next step was to assess the internal consistency reliability of the scale and
subscales. As a total self-efficacy scale, the instrument was comprised of 13 items with 4
sub-scales and a single item (49), which was retained not to compromise the factor
structure. However, item 49 was not included in the calculation of the scale total or in any
of the subscales onto which it previously loaded (i.e. Transportation, Structural and
Communication subscales).
The study hypothesized that the instrument would have a Cronbach’s alpha
greater than 0.70 (Hypothesis 2). Internal Consistency for the scale total was high
(Cronbach’s α = 0.84). This alpha score not only supports the hypothesis, but also
indicates that the items contained in the scale are homogeneous. As seen in Table 12, all
item-to total correlations are above 0.3, which is considered appropriate, and alpha-ifitem-deleted ratings do not seem to suggest strong recommendations for item deletions,
except for item 2 (whose Alpha would increase to 0.85 if deleted). Nonetheless, this item
was retained because there was no other indication in previous item refinement stages
that suggested otherwise. The average item mean was 2.27 and the average inter-item
correlation was 0.32, ranging from 0.62 to .72. The total scale scores ranged from 12 to
42, out of a possible 60, and the mean was 27.27 (SD= 6.51), indicating that participants
felt somewhat efficacious about obtaining the recommended follow up care.
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Table 12. Total scale item statistics (12 items)

Variable
bse44
bse46
bse3
bse27
bse42
bse41
bse47
bse51
bse2
bse13
bse16
bse45

Corrected
Item-Total
Correlation

Cronbach's
Alpha if Item
Deleted

Mean

Std.
Deviation

.529
.560
.429
.531
.578
.487
.582
.595
.314
.553
.473
.607

.831
.828
.837
.831
.828
.833
.826
.825
.853
.829
.834
.824

2.69
2.74
2.08
2.08
2.07
2.07
2.27
2.20
2.71
2.06
2.03
2.30

1.045
1.054
.782
.789
.759
.759
.876
.855
1.195
.779
.774
.945

Item level analysis of subscales: The first subscale, Costs, is comprised of 2 items, and it
shows good internal consistency reliability (α = 0.81). The next subscale, Transportation,
is comprised of 3 items and it also shows good internal consistency reliability (α = 0.81).
Similarly, the structural subscale, has 3 items, and also shows good internal consistency
(α = 0.71). The last subscale, Communication¸is comprised of 4 items, and shows the
lowest Cronbach’s alpha of all subscales (α = 0.64). In fact, item-total statistics suggested
that if item 2 is deleted, Cronbach’s alpha for this subscale would have increased to 0.70.
Corrected item-total correlations, Cronbach’s-alpha-if-item-deleted scores, means and
standard deviations are displayed in table 13.
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Table 13. Item statistics by subscales

Subscale

Costs

Transportation

Structural

Communication

Inter-Item
Correlation
r

Cronbach’s
if item
deleted

Mean

Std.
Deviation

bse44

.69

.

2.69

1.045

bse46

.69

.

2.74

1.054

bse3

.56

.83

2.08

.782

bse27

.74

.65

2.08

.789

bse42

.68

.71

2.07

.759

bse41

.46

.70

2.07

.759

bse47

.50

.65

2.27

.876

bse51

.63

.47

2.20

.855

bse2

.31

.70

2.71

1.195

bse13

.51

.53

2.06

.779

bse16

.46

.56

2.03

.774

bse45

.50

.52

2.30

.945

Variable

Subscale item-total correlations ranged between 0.31 and .74. Not surprisingly,
the smallest item-total correlation was from item 2. Therefore, additional reliability
analyses were conducted, item 2 was removed from the Communication subscale and the
subscale reliability was re-calculated. As a result, internal consistency reliability for this
subscale increased from 0.64 to 0.81. The new item-total statistics showed item-total
correlations higher than 0.30 (0.4, 0.5, and 0.5, for items 13, 16, and 45, respectively),
and deleting any additional items from this subscale would not have increased its internal
consistency.
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Following the elimination of item 2, internal consistency reliability for the scale
total was also recalculated. Cronbach’s did not increase significantly (α [12 items] = 0.84,
α (11 items) = 0.85). New item-to total correlations are displayed in table 14, and all are
above 0.3, and alpha-if-item-deleted ratings do not seem to suggest strong
recommendations for item deletions.

Table 14. Total Scale item statistics (11 items)

Cronbach's
Corrected
Alpha if
Variable Item-Total
Correlation Item Deleted
.559
.840
bse44
.569
.839
bse46
.402
.850
bse3
.544
.840
bse27
.575
.838
bse42
.517
.842
bse41
.572
.838
bse47
.605
.835
bse51
.532
.841
bse13
.467
.846
bse16
.613
.834
bse45
α = 0.85

Mean

Std.
Deviation

2.69
2.74
2.08
2.08
2.07
2.07
2.27
2.20
2.06
2.03
2.30

1.045
1.054
.782
.789
.759
.759
.876
.855
.779
.774
.945

Since eliminating item 2 from the self-efficacy scale did not seem to have a great
impact on the overall reliability scores of the scale, the scale was kept intact. Additional
reasons were taken into consideration when making this decision, which are later
discussed in later sections. Hence, the final self-efficacy instrument contains 12 items.
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Validity Analyses Results
The relationship between the self-efficacy instrument and other theoretically
related instruments were examined in order to obtain evidence of two types of validity:
convergent and discriminant validity. Pearson Product-moment correlation coefficients
were calculated to assess these relationships.
Convergent validity: The study hypothesized that 1) self-efficacy was positively
correlated with Outcomes Expectations (OE; hypothesis 3a), and 2) self-efficacy was
positively correlated with Perceptions of Control (PC; hypothesis 3b). Because outcome
expectations differ by cancer type (breast vs colorectal) independent correlation analyses
were conducted for each group. Eighty-three participants with breast cancer
abnormalities and 12 participants with colorectal cancer abnormalities completed the
outcome expectations questionnaire; eleven participants did not complete these
instruments. Tables 16 and 17, display correlations by cancer type, including only
participants who completed all the questionnaires (n=83 for breast, and n=12 for
colorectal). Table 15 displays correlations between for all participants (breast and
colorectal) for self-efficacy, perceptions of control and depression.
Hypothesis 3a. Results of the correlation analyses showed a small, positive
correlation between SE and OE-Breast (r= .13, p > .05; table 16), and a moderate
negative correlation between SE and OE-Colorectal (r= -.29, p >.05; table 17). Evidence
partially supports the hypothesis, perhaps due to sample size.
Hypothesis 4. There is a significant, small positive correlation between SE and PC
(r= .19, p = .05; table 15). Moreover, PC and depression are significantly, negatively
correlated, as theoretically expected (r= -.364, p<.001),
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Table 15. Correlations and descriptive statistics for self-efficacy, perceptions of control
and self-efficacy scales (breast and colorectal combined).

Scale

Mean

SD

SE

PC

Self-Efficacy (SE)

27.27

6.51

1

Perceptions of Control
(PC)

16.53

4.40

.191*

1

Depression

29.47

6.07

-.024

-.364**

Depression

1

N=106. * denotes correlation is significant at the 0.05 level ** denotes correlation
significant at the 0.01 level (2-tailed).

Table 16. Correlations and descriptive statistics for all scales (breast only)

Scale

Mean

SD

SE

OE-B PC

Self-Efficacy (SE)

27.67

6.29

1

Outcome
Expectations (OE-B)

13.02

1.91

.136

1

Perceptions of
Control (PC)

16.44

4.31

.160

.049

1

Depression

30.21

5.51

.018

-.075

-.352**

N=83. ** denotes correlation significant at the 0.01 level (2-tailed).
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Depression

1

Table 17. Correlations and descriptive statistics for all scales (colorectal only)

Scale

Mean

SD

SE

Self-Efficacy
(SE)

27.58

5.36

1

9.83

2.08

-.292

1

Perceptions of
Control (PC)

18.50

4.58

.253

.029

1

Depression

26.41

7.89

.234

.477

.431

Outcome
Expectations
(OE-C) –
Colorectal

OE-C

PC

Depression

1

N=12.

Discriminant validity: The study hypothesized that there would be a weak
negative association between self-efficacy and depression (hypothesis 3b). Results of the
correlation analyses (in table 15) showed a very weak negative correlation (r = -.02), thus
supporting the hypothesis.
Construct Validity: Results of these correlation analyses provided evidence of
convergent and discriminant validity. Although the associations between SE and OE were
not supported in participants with colorectal abnormalities (n=12), there is evidence of
convergent validity from SE and PC correlations. Hypotheses are supported and there is
evidence of construct validity.
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An additional correlation matrix was generated to assess the relationships between
self-efficacy subscales, depression and perceptions of control. Results (table 18) show
that perceptions of control scores are significantly correlated with two self-efficacy
subscales (transportation r = .30, p < .01; and structural r= .21, p <.01) at a moderate
magnitude. In addition, there is a small negative correlation between depression and three
self-efficacy subscales (transportation r= -.10, p > .05; communication r= -.01, p > .05;
and structural r= -.04, p >.05). Interestingly, depression scores and self-efficacy–costs
are positively correlated.
As explained above, separate analyses were conducted to examine associations
between outcome expectations and the self-efficacy subscales. Correlations displayed in
Table 19 utilized data from 83 participants who had breast abnormalities suspicious for
cancer. Results indicate that there are weak correlations between outcomes expectations
and the following self-efficacy subscales: Costs (r= .009, p >.05), transportation (r= .03,
p >.05) and communication (r= .09, p >.05).Outcome expectations and the structural
subscale are significantly moderately correlated (r= .27, p <.05).
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Table 18. Correlation matrix assessing relationships between perceptions of control and depression by self-efficacy
subscales (breast and colorectal; n=106)

PC
PC

Depression

Costs

Transportation

Structural

1
-.364**

1

.014

.071

1

Transportation

.301**

-.106

.290**

1

Structural

.216*

-.046

.505**

.445**

1

Communication

.036

-.010

.394**

.446**

.450**

Depression
Costs

Communication

**. Correlation is significant at the 0.01 level (2-tailed).
*. Correlation is significant at the 0.05 level (2-tailed).
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1

Table 19. Correlation matrix assessing relationships between perceptions of control, depression, and outcome
expectations by self-efficacy subscales (breast only; n=83)

PC
PC

Depression Costs Transportation Structural Communication

1
-.352**

1

Costs

.041

.001

1

Transportation

.260*

-.045

.287**

1

Structural

.146

-.010

.541**

.375**

1

Communication

.021

.081

.396**

.402**

.416**

1

Outcome
expectations

.049

-.075

.009

.030

.270*

.097

Depression

Outcome
Expectations

**. Correlation is significant at the 0.01 level (2-tailed).
*. Correlation is significant at the 0.05 level (2-tailed).
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1

DISCUSSION
The purpose of the study was to examine the psychometric properties of a selfefficacy measure developed to assess patients’ perceived capability to obtain
recommended follow-up care after receiving an abnormality suspicious for cancer. A
multi-step approach was utilized to assess psychometric properties of the instrument.
Content validity assessments conducted in Phase I of the study provided
information about the items’ semantic and grammatical composition, and relevance to
self-efficacy. Reviewers provided feedback on ways to improve item’s clarity and
recommendations to simplify items by providing low-literacy-appropriate alternatives.
Appendix M lists revisions recommended by reviewers. For example, in items 44 and 46
the word “trouble” was substituted for “difficulty” because a few of the English
reviewers disliked the wording. In Spanish however, the item did not have to be modified
as it already reflected such wording. Items 13 and 2 were reworded to be more actionspecific, as according to Bandura, self-efficacy is a context-specific construct; for that
reason, transforming these items to a more action-oriented composition may be more
appropriate. Consequently, item 13 “I can talk to my health care provider even if I have
difficulty understanding him or her” was modified to “I can ask questions to my health
care provider if I have difficulty understanding him or her;” and item 2 “I can talk to my
health care provider even if he or she does not speak my language” was modified to “I
can request an interpreter if my health care provider does not speak my language”
(additional comments on this item rewording are provided below). Other items such as
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items 27 “I can get transportation to health care appointments even if there is no bus”
and 41 “I can get to a health care appointment even if it is far away” were reworded to
more generalizable terms for populations living outside of Florida who may use other
means of transportation or may reside in pedestrian cities.
Lastly, reviewers’ comments were taken into consideration in the decisionmaking process for item deletion/retention. For example, during the EFA, item-total
statistics suggested that item 2 “I can talk to my health care provider even if he or she
does not speak my language” be removed from the scale. However, following the
removal of this item, psychometric composition of the scale did not improve
significantly. When reviewer’s comments were re-revisited, they suggested that this item
had poor wording, and that the meaning of the item may have been clouded by a minor
language idiosyncrasy. Nonetheless, the item could be salvaged by clarifying a way in
which a person would go about communicating with a health care provider in face of a
language obstacle (i.e. using an interpreter). For this recommendation and the one
described before, item 2 was reworded to “I can request an interpreter if my health care
provider does not speak my language.” Reviewers’ comments on item 49 “I can get
follow-up health care even if I usually use natural remedies to treat disease” were also
re-examined after this item cross-loaded onto 3 other factors. Reviewers thought that this
item lacked clarity and precision; it was also suggested that access to care would not be
compromised if a person uses natural remedies to treat disease. The latter comment may
or may not be true. Nevertheless, most of the reviewers did not like this item and one
said: “I’m not sure if you really need this,” which may be interpreted as if the item is not
relevant or that it does not go with the other items in the scale.
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One of the aims of the study was to determine if the instrument had any
underlying subscales. It was hypothesized that the scale would have at least one main
factor. However, the EFA revealed a 4-factor solution, which is reflective of types of
barriers to care such as costs of care, transportation barriers, structural barriers related to
the health care system, and communication barriers. These logistical, structural, and
interpersonal barriers to care have been well documented in the literature as contributing
factors of health disparities. Barriers to medical care can have an impact in morbidity and
mortality rates (Borrayo & Guarnaccia, 2000; Brown, et al., 2011; Carpenter & Colwell,
1995; Wolff, et al., 2003); therefore, having an instrument that can gauge perceived
capability for obtaining care in the presence of a number of barriers can substantially aid
health care providers in the development and implementation of health care programs that
are aimed at eliminating barriers to care, such as the implementation of patient navigators
who can help attenuate these barriers.
Other study hypotheses stated that the instrument would be found to be a valid
and reliable measure of self-efficacy. As discussed in the result section, most hypotheses
were supported. Self-efficacy and perceptions of control were significantly positively
correlated (r=.19, p<.01); in other words, data suggested that patients who perceive
barriers to care under their control may be more self-efficacious about getting
recommended cancer care. Data also suggested that high levels of perceptions of control
are related to having less depression symptomatology (r= -.36, p<.01). Similarly, feeling
more efficacious may be related to feeling less depressed (r=-.02, p>.01).
When self-efficacy subscales were reviewed independently to examine their
relation to depression, transportation, communication and structural subscales were
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found to negatively correlate with depression as well, except for the costs subscale. The
costs subscale was positively correlated with depression (r= .07, p>.01). Nonetheless,
none of these relationships was statistically significant.
An interestingly significant correlation was found between breast outcome
expectations and the structural subscale (r= .27, p<.01). In other words, participants who
had more positive expectations about having a breast diagnostic exam (e.g. a
mammogram, a biopsy, etc) felt more efficacious about getting the recommended exam
in face of barriers such as distance of a health care facility, familiarity with the facility, or
things that may go wrong there. This finding has some clinical value since the
relationship between these two variables (as seen in figure 1) can impact health
outcomes. In other words, seeing a greater benefit for getting a recommended diagnostic
test, may be related to better feelings of efficacy in face of barriers, such as those in the
structural subscale, hence enhancing the chance of getting the recommended test.
Though, this is only an assertion with little statistical support.
Outcome expectations related to colorectal cancer screening were not correlated
with any other measure (as seen in table 16). As discussed previously, this may be due to
low sample size (n=12); however, instability of this scores may also be attributed to
issues with the instruments utilized to assess outcome expectations. These instruments
have not been validated and the item wording may have been ambiguous for some
participants. Furthermore, the content of this items were closely related to the
participant’s knowledge of breast or colorectal cancer screening. It is uncertain whether
the scores may be a reflection of the lack of participant’s knowledge on cancer screenings
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or expected outcomes from getting screened. Therefore, these results should be
interpreted cautiously.
Information obtained in the study is vital in scale construction, as it is imperative
that researchers use valid and reliable instruments to assess behaviors. As described, a
sound self-efficacy measure can aid investigators and clinicians, who serve populations
similar to the study’s target population, in understanding barriers that might impact
cancer care and how individuals perceive their capacity to circumvent and overcome
them. The implications for practice are extensive.
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IMPLICATIONS FOR PUBLIC HEALTH PRACTICE

There are several implications for public health field in practice, education, and
research. Unfortunately, individuals with limited financial resources and access to care
are disproportionately affected by the burden of cancer. This study can potentially help
public health professionals understand the patient’s perceived barriers to care after cancer
screenings and feelings of efficacy to acquire needed care. Studies that have examined
adherence to screening behaviors indicate that efficacy is indeed an important mediating
factor to obtain cancer screenings related to breast (Champion, et al., 2005; Wehrwein &
Eddy, 1993) and colorectal health (Blalock, DeVellis, Afifi, & Sandler, 1990; DeVellis,
Blalock, & Sandler, 1990; Hoogewerf, Hislop, Morrison, Burns, & Sizto, 1990; Vernon,
Myers, & Tilley, 1997). It is vital that researchers and health professionals be aware of
mediating variables to screening behaviors so that barriers to care can be eliminated and
educational programs that increase participation can be implemented for breast and
colorectal cancer. Identifying which barriers are most impactful can also aid in the
provision of better services, or in the implementations of patient navigators who can help
patients get the recommended care they need. This study developed a valid and reliable
instrument to measure self-efficacy for obtaining follow-up care following an
abnormality suspicious for cancer.
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STUDY LIMITATIONS

This study has some limitations related to its design and methodology. To begin
with, the use of non-probability sampling techniques limits the generalizability of its
results. The nature of a cross-sectional study design precludes the assessment of causal
relationships among the examined variables. To further examine the relationship between
self-efficacy and other variables, a longitudinal study may be necessary. Next, some data
collection procedures such as the use of self-reported data and in-person interviews may
create subject and interviewer biases.
Although the results of this study may not be extrapolated to other populations,
the author asserts that the results may be true to populations with similar characteristics to
this study’s sample. Although the cross-sectional design of this study poses a limitation,
this study may also provide a representative sample of the minority and medically
underserved population of 5 counties in Central West Florida.
A significant limitation to this study was the sample size. Because of a small
sample size and uneven distribution of groups (by language or cancer type) some
analyses could not be performed. Additionally, conducting an exploratory factor analysis
with such a small subject-to-item ratio may have consequences that can threaten the
accuracy of the factors. Nevertheless, EFA examination can provide valuable data on the
composition of the instrument, and can yield possible factors within the scale.
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Psychometric studies that are conducted with participants from different cultural
backgrounds are recommended to examine cross-cultural validity because bias can cause
score differences across groups, and invalidate inferences drawn from these scores.
Although this type of validity was not assessed in the project because of low sample size,
issues related to cross-cultural item bias (item translation and complex wording of items)
were addressed by revising some items based on feedback provided by content validity
reviewers, who commented on these very same issues. Furthermore, exploring possible
cross-cultural differences in the theoretical definition of the construct of self-efficacy
goes beyond the scope of this project, and it is an area to explore in future studies.

In hindsight:
The content validity rating form response choices were a little ambiguous, as
somewhat relevant and slightly relevant can be interpreted as the same response. As to
the clarity response scale, providing a response option labeled as “item is not clear” is not
ideal when raters can rate items as “need minor/major revisions.” Providing a “need to
revise” option can also signify that the item is not clear, and as it needs revisions as a
result. A response option labeled as “item is not clear at all” would have been more
appropriate.
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FUTURE DIRECTIONS

The study gathered evidence of two types of validity: construct validity (by
convergent and discriminant validity), and content validity. More research is needed to
explore other types of validity, including predictive validity. Estimating the degree to
which the measure may predict receipt of follow-up care would be a powerful
characteristic to add to its psychometric properties. Many may argue that beliefs about
one’s capability to perform a behavior may not be powerful enough to achieve a
behavioral outcome. Yet, based on the theoretical basis of social cognitive theory,
cognition and behavior are intricately related, and thoughts of efficacy can be a powerful
predictor of behavior.
After conducting this study, it is imperative to test the revised self-efficacy scale
and reassess its performance once again. As in many social disciplines measures are
constantly reassessed. It would be beneficial to test the revised instrument with larger
samples, more diverse populations, and even different types of cancer.
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APPENDIX A:
ENGLISH DEMOGRAPHIC QUESTIONNAIRE

Now I am going to ask you some questions about yourself and your
background.
1. What is your marital status?
1.
Single/Never married
2.
Married
3.
Divorced/separated
4.
Widowed
5.
Living with a same gender partner
2. Gender
0. Female
1. Male
3. What is the highest grade or year of education that you have completed?
_________
4. Do you identify yourself as Hispanic or Latino/a?
0.
No
1.
Yes
5.

What is your race (read answer choices)?
1. White
2. Black/African American
3. Asian
4. Native Hawaiian/Other Pacific Islander
5. Native American/Alaskan Native
6. Other____________________________________
7. Choose not to answer
8. Unsure/does not know
(if patient is confused by this question, ask alternative race question)

6. Where were you born?_________________________________(country)
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7. What is your native language?____________________________________
8. What is your primary language?
1.
English
2.
Spanish
3.
Haitian Creole
4.
Vietnamese
5.
Portuguese Creole
6.
Albanian
7.
Cambodian
8.
Russian
9.
Somali
10.
Other (__________________________________)
9.
10.

How many people (adults and children) live with you? _____________
How many dependents live with you?_____________

11.

What is your housing status (read answer choices, but not words in
parentheses)?
1.
Renting (apartment, home, condo, mobile home)
2.
Own (home, condo, mobile home)
3.
Staying with family or friends
4.
Other (__________________________________)

12. How long have you lived at your current home?
____________
_______________
Years
Months
13.

Are you currently working outside the home for pay?
0.
No current employment
1.
Part-time employment
2.
Full-time employment

14.

What is your occupation?_______________________________

15.
Do you have a primary care provider, like a doctor or clinic that you go to
most of the time? A primary care provider is a physician, nurse practitioner, or
medical clinic that you go to when you are sick or need a check-up.
0.
No
1.
Yes
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16. What is the name of your primary care provider?
________________________________________________________
17. Is your primary care provider a doctor, physician’s assistant, or nurse
practitioner?
1.
Doctor (internist, ob/gyn, family practitioner)
2.
Physician’s assistant
3.
Nurse practitioner
4.
Other
5.
Does not know
18. Patient navigation is when a trained person helps or guides you to get the
health care or treatment you need. This help may include arranging transportation,
providing information you need, or helping to get financial support. Have you
ever been navigated?
0.
No
1.
Yes (list date and health condition navigated _________________)
19. What is your annual household income?
0.
Zero
1.
$1 to $9,999
2.
$10,000 to $19,999
3.
$20,000 to $29,999
4.
$30,000 to $39,999
5.
$40,000 to $49,999
6.
$50,000 to $74,999
7.
$75,000 to $99,999
8.
$100,000 or more
20.

What is today’s date?

__ __ / __ __ / __ __ __ __
Month Day
Year
21. Randomization group
1.
Control
2.
Navigated
22.

Patient ID _______________________________________
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APPENDIX B:
SPANISH DEMOGRAPHIC QUESTIONNAIRE
Ahora le voy a hacer unas preguntas acerca de sus datos demográficos.
1. ¿Cuál es su estado civil?
1.
Soltero(a)/jamás casado(a)
2.
Casado(a)
3.
Divorciado(a)/separado(a)
4.
Viudo(a)
5.
Unión libre con una persona de su mismo sexo
2. ¿Cuál es su sexo?
0. Femenino
1. Masculino
3.¿Cuál ha sido el grado de educación más alto que usted ha completado?_________
4. ¿Usted se identifica como Hispano(a) o Latino(a)?
0.
No
1.
Si
5.

8.

¿Cuál es su raza (read answer choices)?
1. Blanca
2. Negra/Afro-Americana
3. Asiática
4. Nativa de Hawai/de las Islas del Pacífico
5. Indígena Americana/Nativa de Alaska
6. Otra
7. Prefiere no responder
No está seguro/ No sabe

(if patient is confused by this question, ask alternative race question)
6. ¿Dónde Nació?______________________ ____________(País)
7. ¿Cuál es su lengua nata?________________ ____________________
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8. ¿Cuál es su idioma principal?
1.
Inglés
2.
Español
3.
Criollo (Haiti)
4.
Vietnamita
5.
Criollo portugués
6.
Albanés
7.
Cambodiano
8.
Ruso
9.
Somalí
10.
Otro(__________________________________)
9.

¿Cuántas personas (adultos y niños) viven con usted?_____________

10.

¿Cuántos niños que dependen de usted viven en su casa?_____________

11.

¿Cuál es su estatus de vivienda actual (read answer choices, but not words in
parentheses)?
1.
Renta (apartamento, casa, condominio, casa móvil)
2.
dueño de casa, condominio, o casa móvil
3.
Se queda en casa de familiares o amigos
4.
Otro (__________________________________)

12. ¿Cuánto tiempo ha vivido en su vivienda actual?
____________
_______________
Años
Meses
13.

¿Actualmente trabaja afuera de casa a sueldo?
0.
No actualmente no trabaja
1.
Trabaja medio tiempo
2.
Trabaja tiempo completo

14. ¿Cuál es su profesión?______________________________________
15. ¿Usted tiene un proveedor de servicios de salud primario, como por ejemplo un
doctor o alguna clínica a la cual usted asiste la mayor parte del tiempo? Un proveedor
de servicios de salud primario es un médico, un(a) enfermero(a), o una clínica a la
que usted va cuando se siente enfermo(a) o necesita una revisión médica.
0. No
1. Si
16. ¿Cómo se llama su proveedor de servicios de salud primario?
______________________________________________
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17. ¿Es su proveedor de servicios de salud primario un doctor, un asistente médico, o
un(a) enfermero(a)?
1. Doctor (practicante, ginecólogo, médico familiar)
2.
Asistente médico
3.
Enfermero(a)
4.
Otro
5.
No sabe
18. Navegación de Pacientes es cuando una persona entrenada le ayuda o le guía a través
del cuidado médico o del tratamiento. Esta ayuda puede incluir hacer arreglos de
transporte, proporcionar información, o ayudar a obtener ayuda financiera. ¿Alguna vez
ha sido navegado?
0.
No
1.
Si (escriba la fecha y la condición de salud por la que se le navegó
19. ¿Cuál es el ingreso anual de su casa?
0. Cero
1. $1 a $9,999
2. $10,000 a $19,999
3. $20,000 a $29,999
4. $30,000 a $39,999
5. $40,000 a $49,999
6. $50,000 a $74,999
7. $75,000 a $99,999
8. $100,000 o más
20.

¿Qué fecha es hoy?
__ __ / __ __ / __ __ __ __
Mes Día
Año

21. Randomization Group
1.
Control
2.
Navigated
22.

Patient ID _______________________________________
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APPENDIX C:
ENGLISH CANCER RESPONSE EFFICACY SCALE

]Breast only] The following items ask about your concerns about getting breast
cancer. For each question, please CIRCLE the ONE answer that best describes
your feelings.
1.

When breast cancer is found early, it can be cured.
1.
Strongly agree
2.
Agree
3.
Neither agree nor disagree
4.
Disagree
5
Strongly disagree

2.

When a woman examines her own breasts, she can detect breast cancer at an early
stage.
1.
Strongly agree
2.
Agree
3.
Neither agree nor disagree
4.
Disagree
5
Strongly disagree

3.

Having a mammogram will tell a woman whether or not she has breast cancer.
1.
Strongly agree
2.
Agree
3.
Neither agree nor disagree
4.
Disagree
5
Strongly disagree

4.

When a doctor examine a woman’s breasts, the exam will tell a woman whether
she has breast cancer.
1.
Strongly agree
2.
Agree
3.
Neither agree nor disagree
4.
Disagree
5
Strongly disagree
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5.

When breast cancer screening shows that something is wrong, the chance for
cure is great.
1.
Strongly agree
2.
Agree
3.
Neither agree nor disagree
4.
Disagree
5
Strongly disagreeInstructions
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APPENDIX C (Continued)
[Colorectal only] The following items ask about your concerns about getting
colorectal cancer. For each question, please CIRCLE the ONE answer that best
describes your feelings.

1.

When colorectal cancer is found early, it can be cured.
1.
2.
3.
4.
5

2.

When colorectal polyps (growths) are found and removed, colorectal cancer can
be prevented.
1.
2.
3.
4.
5

3.

Strongly agree
Agree
Neither agree nor disagree
Disagree
Strongly disagree

Having colorectal cancer screening will tell a person whether or not he or she has
colorectal cancer.
1.
2.
3.
4.
5

4.

Strongly agree
Agree
Neither agree nor disagree
Disagree
Strongly disagree

Strongly agree
Agree
Neither agree nor disagree
Disagree
Strongly disagree

When colorectal cancer screening shows that something is wrong, the chance for
cure is great.
1.
2.
3.
4.
5

Strongly agree
Agree
Neither agree nor disagree
Disagree
Strongly disagree
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APPENDIX D:
SPANISH CANCER RESPONSE EFFICACY

[Breast only] Las siguientes oraciones se refieren a su inquietud de llegar a
tener cáncer de seno. Para cada pregunta, circule la única respuesta que
describa mejor sus sentimientos.
1.

Cuando el cáncer de seno se encuentra temprano, puede curarse.
1.
Estoy completamente de acuerdo.
2.
Estoy de acuerdo.
3.
Ni estoy de acuerdo ni en desacuerdo.
4.
No estoy de acuerdo.
5
No estoy de acuerdo en absoluto.

2.

Cuando una mujer se hace un examen de sus propios senos, puede detectar el
cáncer en una fase temprana.
1.
Estoy completamente de acuerdo.
2.
Estoy de acuerdo.
3.
Ni estoy de acuerdo ni en desacuerdo.
4.
No estoy de acuerdo.
5
No estoy de acuerdo en absoluto.

3.

Hacerse una mamografía le dirá a una mujer si tiene cáncer de seno.
1.
Estoy completamente de acuerdo.
2.
Estoy de acuerdo.
3.
Ni estoy de acuerdo ni en desacuerdo.
4.
No estoy de acuerdo.
5
No estoy de acuerdo en absoluto.

4.

Cuando un doctor examina los senos de una mujer, el examen le dirá a ella si
tiene o no cáncer de seno.
1.
Estoy completamente de acuerdo.
2.
Estoy de acuerdo.
3.
Ni estoy de acuerdo ni en desacuerdo.
4.
No estoy de acuerdo.
5
No estoy de acuerdo en absoluto.

5.

Cuando una prueba de detección del cáncer de seno dice que algo está mal, hay un
gran chance de cura.
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1.
2.
3.
4.
5.

Estoy completamente de acuerdo.
Estoy de acuerdo.
Ni estoy de acuerdo ni en desacuerdo.
No estoy de acuerdo.
No estoy de acuerdo en absoluto.
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APPENDIX D (Continued)

[Colorectal only] Las siguientes afirmaciones se refieren a su inquietud de
llegar a tener cáncer colorrectal. Para cada pregunta, circule la única respuesta
que describa mejor sus sentimientos.
1.

Cuando el cáncer colorrectal se encuentra temprano, puede curarse.
1.
2.
3.
4.
5

2.

Cuando se encuentran pólipos(crecimientos) colorrectales y se quitan, el cáncer
colorrectal puede prevenirse.
1.
2.
3.
4.
5

3.

Estoy completamente de acuerdo.
Estoy de acuerdo.
Ni estoy de acuerdo ni en desacuerdo.
No estoy de acuerdo.
No estoy de acuerdo en absoluto.

Hacerse una prueba de detección de cáncer colorrectal dice si una persona tiene
cáncer colorrectal.
1.
2.
3.
4.
5

4.

Estoy completamente de acuerdo.
Estoy de acuerdo.
Ni estoy de acuerdo ni en desacuerdo.
No estoy de acuerdo.
No estoy de acuerdo en absoluto.

Estoy completamente de acuerdo.
Estoy de acuerdo.
Ni estoy de acuerdo ni en desacuerdo.
No estoy de acuerdo.
No estoy de acuerdo en absoluto.

Cuando los resultados de una prueba de detección de cáncer colorrectal dicen que
algo está mal, hay una gran posibilidad de cura.
1.
2.
3.
4.
5

Estoy completamente de acuerdo.
Estoy de acuerdo.
Ni estoy de acuerdo ni en desacuerdo.
No estoy de acuerdo.
No estoy de acuerdo en absoluto.
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APPENDIX E:
ENGLISH PERSONAL MASTERY SCALE

Please circle the one response that describes how strongly you agree or
disagree with these statements about yourself.
(1)
(2)
(3)
(4)
(5)
Strongly Agree Neutral Disagree Strongly
Agree
Disagree

1. There is really no way
I can solve problems I have.

1

2

3

4

5

2. Sometimes I feel that
I am being pushed around in life.

1

2

3

4

5

3. I have little control
over the things that happen to me.

1

2

3

4

5

4. I can do just about everything
I set my mind to do.

1

2

3

4

5

5. I often feel helpless in dealing
with the problems of life.

1

2

3

4

5

6. What happens to me in the
future mostly depends on me.

1

2

3

4

5

7. There is little I can do
to change many of the
important things in my life.

1

2

3

4

5
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APPENDIX F:
SPANISH PERSONAL MASTERY SCALE

Por favor haga un circulo alrededor la respuesta que describa lo que piensa
(estas muy de acuerdo o no estas muy de acuerdo) sobre usted misma.
(1)
Estoy
totalmente de
acuerdo

(2)

(3)

(4)

(5)

Estoy
de acuerdo

Estoy
neutral

Estoy en
desacuerdo

1

2

3

4

5

2. Algunas veces siento que estoy siendo 1
empujada por la vida.

2

3

4

5

3. Yo tengo muy poco control sobre
las cosas que me pasan.

1

2

3

4

5

4. Yo puedo hacer cualquier cosa si
en verdad me lo propongo.

1

2

3

4

5

5. Con frecuencia me siento inútil
para confrontar los problemas de
la vida.

1

2

3

4

5

6. Lo que me pase en el futuro
depende en su mayor parte de mí.

1

2

3

4

5

7. Hay muy poco que yo pueda hacer
para cambiar muchas de las cosas
importantes en mi vida.

1

2

3

4

5

1. En realidad no hay ninguna
manera en que yo pueda solucionar
algunos de los problemas que tengo.
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Estoy
totalemente
en desacuerdo

APPENDIX G:
ENGLISH PATIENT HEALTH QUESTIONNAIRE –DEPRESSION MODULE 9

Over the last 2 weeks, how often have you been bothered by any of the
following problems?
(Check one answer for each item.)
Not at
all
(1)

Several
Days
(2)

More
than half
of the
days (3)

Nearly
every day
(4)

































































1. Little interest or pleasure in doing
things
2. Feeling down, depressed, or
hopeless
3. Trouble falling or staying asleep or
sleeping too much
4. Feeling tired or having little energy
5. Poor appetite or overeating
6. Feeling bad about yourself— or
that you are a failure or have let
yourself or your family down
7. Trouble concentrating on things
such as reading the newspaper or
watching television
8. Moving or speaking so slowly that
other people could have noticed? Or
the opposite—being so fidgety or
restless that you have been moving
around
a lot more than usual
9. Thoughts that you would be better
off dead or of hurting yourself
10. If you checked off any problems
on this page, how difficult have
these problems made it for you to
do your work, take care of things
at home, or get along with people?
(please circle one answer)

1.
2.
3.
4.
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not difficult at all
somewhat difficult
very difficult
extremely difficult

APPENDIX H:
SPANISH PATIENT HEALTH QUESTIONNAIRE –DEPRESSION MODULE 9

Durante las ultimas 2 semanas, con que frecuencia le han molestado los
siguientes problemas?
(Marque la respuesta correcta en frente de cada frase)

1. Tener poco interés o placer en hacer las
cosas
2. Sentirse desanimada, deprimida, o sin
esperanza.
3. Con problemas para dormirse o mantenerse
dormida, o en dormir demasiado
4. Sentirse cansada o tener poca energía
5. Tener poco apetito o comer en exceso.
6. Sentirse mal acerca de uno misma o
sentirse que es un fracaso o que se ha
decepcionado a si misma o a su familia
7. Tener dificultad para concentrarse en cosas
como leer el periódico o ver televisión.
8. Se mueve o habla tan lentamente que otra
Gente se podría dar cuenta, o de lo contrario,
está tan agitada o inquieta que se mueve
mucho más de lo acostumbrado.
9. Ha pensado que seria mejor estar muerta o
en hacerse daño de alguna manera.
10. Si usted marco afirmativo (si) a
cualquiera de los problemas en este
cuestionario, cuán difícil se le ha hecho
cumplir con su trabajo, atender su casa, o
relacionarse con otras personas debido a
estos problemas? (Por favor haga un circulo
alrededor de una respuesta

Nunca
(1)

Varios
días
(2)

Más de
la mitad
de los
días (3)

Casi
todos
los días
(4)

































































1.
2.
3.
4.
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Nada en absoluto
Un poco difícil
Muy difícil
Extremamente difíci

APPENDIX I:
ENGLISH SELF-EFFICACY MEASURE
Follow up health care includes any additional doctor’s appointments and other tests that your
doctor recommends.
The following items ask whether you will be able to get follow up health care for the cancer
screening that you recently received. Please indicate how much you agree with the
following statements.
Strongly
Agree
Neither
Disagree Strongly
Agree
agree nor
Disagree
disagree
(1)
(2)
(3)
(4)
(5)
1. I can get follow-up health care
even if I am upset.

1

2

3

4

5

2. I can talk to my health care
provider even if he or she does
not speak my language.

1

2

3

4

5

3. I can get transportation to
health care appointments even
if I cannot drive a car.

1

2

3

4

5

4. I can have someone help me
read health care materials if I
have trouble reading.

1

2

3

4

5

5. I can take time off work to go
to health care appointments.

1

2

3

4

5

6. I can get follow-up health care
even if I have to care for my
family.

1

2

3

4

5

7. I can get follow-up health care
even if I am tired.

1

2

3

4

5

8. I can get follow-up health care
even if my friends do not want
me to.

1

2

3

4

5
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Follow up health care includes any additional doctor’s appointments and other tests that your
doctor recommends.
The following items ask whether you will be able to get follow up health care for the cancer
screening that you recently received. Please indicate how much you agree with the
following statements.
Strongly
Strongly
Agree
Neither Disagree
Disagree
Agree
agree
nor
(4)
(5)
(1)
(2)
disagree
(3)
9. I can get follow-up care even
1
2
3
4
5
if I do not have immigration
papers.
10. I can get follow up health
care even if I do not like my
health care provider.

1

2

3

4

5

12. I can get follow-up health
care even if I believe that my
life is in God’s hands.

1

2

3

4

5

13. I can talk to my health care
provider even if I have
difficulty understanding him
or her.

1

2

3

4

5

14. I can get transportation to
health care appointments
even if I do not have a car.

1

2

3

4

5

15. I can get follow-up health
care even if I am not
motivated to go to the clinic.

1

2

3

4

5

16. I can fill out forms at the
clinic even if I have trouble
writing.

1

2

3

4

5

17. I can take time off work to
go to health care
appointments even if I do
not get paid.

1

2

3

4

5

18. I can find someone to care
for my family members so
that I can attend clinic
appointments.

1

2

3

4

5
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Follow up health care includes any additional doctor’s appointments and other tests that your
doctor recommends.
The following items ask whether you will be able to get follow up health care for the cancer
screening that you recently received. Please indicate how much you agree with the
following statements.
Disagree Strongly
Neither
Agree
Strongly
Disagree
agree nor
Agree
disagree
(5)
(4)
(3)
(2)
(1)
19. I can find people who can help
1
2
3
4
5
me get follow-up health care.
20. I can get follow-up health care
even if I am worried.

1

2

3

4

5

21. I can get follow-up health care
even if I am afraid to talk to
my health care provider.

1

2

3

4

5

22. I can get follow-up care even
if I am not a United States
citizen.

1

2

3

4

5

23. I can get follow-up health care
even if the process is
uncomfortable.

1

2

3

4

5

24. I can get follow-up health care
even if I do not want to know
if I am sick.

1

2

3

4

5

25. I can get follow-up health care
even if I am depressed.

1

2

3

4

5

26. I can get follow-up health care
even if I do not know what
questions to ask.

1

2

3

4

5

27. I can get transportation to
health care appointments even
if there is no bus.

1

2

3

4

5

28. I can talk to my supervisor
about getting time off work to
go to health care
appointments.

1

2

3

4

5
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Follow up health care includes any additional doctor’s appointments and other tests that your
doctor recommends.
The following items ask whether you will be able to get follow up health care for the cancer
screening that you recently received. Please indicate how much you agree with the
following statements.
Disagree

Strongly
Disagree

(2)

Neither
agree nor
disagree
(3)

(4)

(5)

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

32. I can ask for help to complete
health forms even if they are
in a different language.

1

2

3

4

5

33. I can find people who can give
me good advice about my
health care.

1

2

3

4

5

34. I can get follow-up health care
even if I feel sick.

1

2

3

4

5

35. I can talk to my supervisor
about my health even if I am
afraid that I will be fired.

1

2

3

4

5

36. I can get follow-up health care
even if a member of my family
is upset about my health.

1

2

3

4

5

37. I can get follow-up health care
even if I have trouble talking
to my health care provider.

1

2

3

4

5

38. I can find people who can help
me read things that I do not
understand.

1

2

3

4

5

29. I can get follow-up health care
even if someone in my family
does not want me to.
30. I can get follow-up health care
even if I am afraid that I may
have cancer.
31. I can get follow-up health care
even if the process is scary.

Strongly
Agree

Agree

(1)
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Follow up health care includes any additional doctor’s appointments and other tests that your
doctor recommends.
The following items ask whether you will be able to get follow up health care for the cancer
screening that you recently received. Please indicate how much you agree with the
following statements.
Strongly
Agree

Agree

(1)
39. I can get follow-up health care
even if I have to wait a long
time at the clinic.

Disagree

Strongly
Disagree

(2)

Neither
agree nor
disagree
(3)

(4)

(5)

1

2

3

4

5

40. I can get follow-up health care
even if I feel pain.

1

2

3

4

5

41. I can get to a health care
appointment even if it is far
away.

1

2

3

4

5

42. I can find people who can
help me get to my clinic
appointments.

1

2

3

4

5

43. I can get follow-up health care
even if I do not feel sick.

1

2

3

4

5

44. I can get medicines even if I
have trouble paying for them.

1

2

3

4

5

45. I can get follow-up health care
even if I do not understand the
health problem.

1

2

3

4

5

46. I can get follow-up health care
even if I have trouble paying
for it.

1

2

3

4

5

47. I can get follow-up health care
even if I get frustrated with
things that go wrong at the
clinic.

1

2

3

4

5

48. I can get follow-up health care
even if I do not feel pain.

1

2

3

4

5

49. I can get follow-up health care
even if I usually use natural
remedies to treat disease.

1

2

3

4

5
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Follow up health care includes any additional doctor’s appointments and other tests that your
doctor recommends.
The following items ask whether you will be able to get follow up health care for the cancer
screening that you recently received. Please indicate how much you agree with the
following statements.
Disagree

Strongly
Disagree

(2)

Neither
agree nor
disagree
(3)

(4)

(5)

1

2

3

4

5

1

2

3

4

5

Strongly
Agree

Agree

(1)
50. I can get follow-up health care
even if I feel hopeless.
51. I can get to a health care
appointment that is in a place I
have never been to.
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APPENDIX J:
SPANISH SELF-EFFICACY MEASURE
Los Cuidados Médicos de Seguimiento incluyen cualquier cita y prueba adicional que
su doctor recomienda.
Las siguientes oraciones le preguntan si usted podrá obtener cuidados médicos de
seguimiento después de las pruebas de detección de cáncer que se hizo
recientemente. Circule la respuesta que indique en qué medida usted está de
acuerdo con las siguientes oraciones.

1. Puedo obtener cuidados
médicos de seguimiento
incluso si estoy disgustado.
2. Puedo hablar con un
profesional de la salud
incluso si éste no habla mi
idioma.
3. Puedo conseguir transporte
para ir a las citas médicas
incluso si no puedo manejar
un auto.
4. Puedo pedirle a alguien que
me ayude a leer los
documentos médicos si
tengo problemas para leer.
5. Puedo tomar horas libres en el
trabajo para ir a mis citas
médicas.
6. Puedo obtener cuidados
médicos de seguimiento
incluso si tengo que cuidar
de mi familia.
7. Puedo obtener cuidados
médicos de seguimiento
incluso si estoy cansado.
8. Puedo obtener cuidados
médicos de seguimiento
incluso si mis amigos no lo
quieren.

Estoy
completamente
de acuerdo

Estoy de
acuerdo

Ni estoy de
acuerdo ni
en desacuerdo

No estoy
de
acuerdo

(1)

(2)

(3)

(4)

No estoy
de
acuerdo
en
absoluto
(5)

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5
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Los Cuidados Médicos de Seguimiento incluyen cualquier cita y prueba adicional que
su doctor recomienda.
Las siguientes oraciones le preguntan si usted podrá obtener cuidados médicos de
seguimiento después de las pruebas de detección de cáncer que se hizo
recientemente. Circule la respuesta que indique en qué medida usted está de
acuerdo con las siguientes oraciones.
Estoy
completamente
de acuerdo

Estoy de
acuerdo

(1)

(2)

9. Puedo obtener cuidados médicos de
seguimiento incluso si no tengo
papeles de inmigración.

1

2

10. Puedo obtener cuidados médicos de
seguimiento incluso si no me gusta
el profesional de la salud.

1

11. Puedo obtener cuidados médicos de
seguimiento incluso si estoy
ocupado.

Ni estoy
de
acuerdo
ni en desacuerdo

No
estoy de
acuerdo

(4)

No
estoy de
acuerdo
en
absoluto
(5)

3

4

5

2

3

4

5

1

2

3

4

5

12. Puedo obtener cuidados médicos de
seguimiento incluso si creo que mi
vida está en manos de Dios.

1

2

3

4

5

13. Puedo organizar una cita para hablar
con mi profesional de la salud
incluso si tengo dificultad para
entenderle.

1

2

3

4

5

14. Puedo conseguir transporte para ir a
las citas médicas incluso si no
tengo auto.

1

2

3

4

5

15. Puedo obtener cuidados médicos de
seguimiento incluso si no estoy
motivado para ir a la clínica.

1

2

3

4

5

16. Puedo llenar formularios en la
clínica incluso si tengo problemas
para escribir.

1

2

3

4

5

17. Puedo tomar horas libres en el
trabajo para ir a citas médicas
incluso si no me pagan.

1

2

3

4

5
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(3)

Los Cuidados Médicos de Seguimiento incluyen cualquier cita y prueba adicional que
su doctor recomienda.
Las siguientes oraciones le preguntan si usted podrá obtener cuidados médicos de
seguimiento después de las pruebas de detección de cáncer que se hizo
recientemente. Circule la respuesta que indique en qué medida usted está de
acuerdo con las siguientes oraciones.
Estoy
completamente
de acuerdo

Estoy de
acuerdo

(1)

(2)

Ni estoy
de
acuerdo
ni en
desacuerdo

No
estoy de
acuerdo

(4)

No
estoy de
acuerdo
en
absoluto
(5)

(3)
18. Puedo buscar a alguien que cuide de
mi familia para que yo pueda asistir
a las citas en la clínica.

1

2

3

4

5

19. Puedo encontrar a personas que me
ayuden a obtener cuidados médicos
de seguimiento.

1

2

3

4

5

20. Puedo obtener cuidados médicos de
seguimiento incluso si estoy
preocupado.

1

2

3

4

5

21. Puedo obtener cuidados médicos de
seguimiento incluso si me asusta
hablar con mi profesional de la
salud.

1

2

3

4

5

22. Puedo obtener cuidados médicos de
seguimiento incluso si no soy
ciudadano de los Estados Unidos.

1

2

3

4

5

23. Puedo obtener cuidados médicos de
seguimiento incluso si el proceso es
incómodo.

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

26. Puedo obtener cuidados médicos de
seguimiento incluso si no sé qué
preguntas hacer.

1

2

3

4

5

27. Puedo conseguir transporte para ir a
las citas médicas incluso si no hay
guagua (autobús).

1

2

3

4

5

24. Puedo obtener cuidados médicos de
seguimiento incluso si no quiero
saber si estoy enfermo.
25. Puedo obtener cuidados médicos de
seguimiento incluso si estoy
deprimido.
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Los Cuidados Médicos de Seguimiento incluyen cualquier cita y prueba adicional que
su doctor recomienda.
Las siguientes oraciones le preguntan si usted podrá obtener cuidados médicos de
seguimiento después de las pruebas de detección de cáncer que se hizo
recientemente. Circule la respuesta que indique en qué medida usted está de
acuerdo con las siguientes oraciones.

Estoy
completamente
de acuerdo

Estoy de
acuerdo

(1)

(2)

Ni estoy
de
acuerdo
ni en
desacuerdo

No
estoy de
acuerdo

(4)
(3)

No
estoy de
acuerdo
en
absolut
o
(5)

28. Puedo hablar con mi supervisor
sobre la posibilidad de tomar horas
libres en el trabajo para ir a citas
médicas.

1

2

3

4

5

29. Puedo obtener cuidados médicos de
seguimiento incluso si alguien de
mi familia no quiere que lo haga.

1

2

3

4

5

1

2

3

4

5

31. Puedo obtener cuidados médicos de
seguimiento incluso si el proceso
me asusta.

1

2

3

4

5

32. Puedo pedir ayuda para llenar
formularios de salud incluso si
están escritos en un idioma distinto.

1

2

3

4

5

33. Puedo encontrar a personas que me
den buenos consejos sobre el
cuidado de mi salud.

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

30. Puedo obtener cuidados médicos de
seguimiento incluso si me da miedo
que pueda tener cáncer.

34. Puedo obtener cuidados médicos de
seguimiento incluso si me siento
enfermo.
35. Puedo hablar con mi supervisor
sobre mi salud incluso si tengo
miedo de que me bote (despida).
36. Puedo obtener cuidados médicos de
seguimiento incluso si alguien de
mi familia está disgustado debido a
mi salud.
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Los Cuidados Médicos de Seguimiento incluyen cualquier cita y prueba adicional que
su doctor recomienda.
Las siguientes oraciones le preguntan si usted podrá obtener cuidados médicos de
seguimiento después de las pruebas de detección de cáncer que se hizo
recientemente. Circule la respuesta que indique en qué medida usted está de
acuerdo con las siguientes oraciones.

37. Puedo obtener cuidados médicos de
seguimiento incluso si tengo
problemas para hablar con mi
profesional de la salud.
38. Puedo encontrar personas que me
pueden ayudar a leer cosas que no
entiendo.
39. Puedo obtener cuidados médicos de
seguimiento incluso si tengo que
esperar mucho tiempo en la clínica.
40. Puedo obtener cuidados médicos de
seguimiento incluso si siento dolor.
41. Puedo ir a una cita médica incluso si
está lejos.
42. Puedo encontrar personas que
pueden ayudarme a llegar a mis
citas de la clínica.
43. Puedo obtener cuidados médicos de
seguimiento incluso si no me siento
enfermo.
44. Puedo obtener medicinas incluso si
me es difícil pagarlas.
45. Puedo obtener cuidados médicos de
seguimiento incluso si no entiendo
el problema médico.

Estoy
completamente
de acuerdo

Estoy de
acuerdo

(1)

(2)

1

2

1

Ni estoy
de
acuerdo
ni en desacuerdo

No estoy
de
acuerdo

(4)

No
estoy de
acuerdo
en
absoluto
(5)

3

4

5

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5
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(3)

Los Cuidados Médicos de Seguimiento incluyen cualquier cita y prueba adicional que
su doctor recomienda.
Las siguientes oraciones le preguntan si usted podrá obtener cuidados médicos de
seguimiento después de las pruebas de detección de cáncer que se hizo
recientemente. Circule la respuesta que indique en qué medida usted está de
acuerdo con las siguientes oraciones.

46. Puedo obtener cuidados médicos de
seguimiento incluso si me es difícil
pagarlos.
47. Puedo obtener cuidados médicos de
seguimiento incluso si me frustran
las cosas que no van bien en la
clínica.
48. Puedo obtener cuidados médicos de
seguimiento incluso si no siento
dolor.
49. Puedo obtener cuidados médicos de
seguimiento incluso si
normalmente uso remedios
naturales para tratar las
enfermedades.
50. Puedo obtener cuidados médicos de
seguimiento incluso si he perdido
las esperanzas.
51. Puedo ir a una cita médica que está
en un lugar que no conozco.

Estoy
completamente
de acuerdo

Estoy de
acuerdo

(1)

(2)

1

2

1

Ni estoy
de
acuerdo
ni en desacuerdo

No
estoy de
acuerdo

(4)

No
estoy de
acuerdo
en
absoluto
(5)

3

4

5

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5
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(3)

APPENDIX K:
CONTENT VALIDITY REVIEWER INVITATION LETTERS
Dear XXX,
I’m currently conducting a thesis project entitled “Evaluating the psychometric
properties of a self-efficacy measure within a Patient Navigator Research Project” under
the supervision of Dr. Oliver Massey, director of the Division of Policy and Services
Research and Evaluation at the Florida Mental Health Institute. The goal of my study is
to examine the psychometric properties of a self-efficacy measure related to obtaining
follow-up care after receiving results suspicious for cancer.
The instrument was initially developed and pilot tested by an NCI-funded study
titled “Patient Navigation Research Project.” A team of investigators developed the
measure to assess participants’ perceived capability to obtaining follow up care after
getting abnormal results suspicious for cancer. By conducting my research project, I hope
to refine the instrument items and gather evidence of the instrument’s psychometric
properties. In order to do that, I will conduct content validity assessments. As you know,
content validity is an evaluation of whether items in a scale are relevant and measure all
aspects of a construct.
I would like to ask for your assistance in serving as a content validity reviewer
based on your expertise on the topic of self-efficacy and your ample experience with
instrument development. If you agree to take part, I will send you an email containing a
brief rating form. The form asks for you to rate each item based on its relation to the
underlying construct of self-efficacy, rate each item’s level of clarity and provide
suggestions for revisions. This form takes about 15-20 minutes to complete. Once you
have completed the form, I will ask you to return it to me electronically. Upon the
completion of my thesis project, and if you are interested, I will be happy to provide you
with a summary of the results and a copy of the final instrument.
Thank you so much for considering my request for assistance with my thesis
project. Please let me know your decision to participate at your earliest convenience.
Please feel free to contact me should you have any questions regarding the content
validity evaluation or my project.
Sincerely,

Mariana Arevalo
MPH candidate, Community and Family Health
University of South Florida
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APPENDIX K (Continued)
Dear XXX,
I’m currently conducting a thesis project entitled “Evaluating the psychometric
properties of a self-efficacy measure within a Patient Navigator Research Project” under
the supervision of Dr. Oliver Massey, director of the Division of Policy and Services
Research and Evaluation at the Florida Mental Health Institute. The goal of my study is
to examine the psychometric properties of a self-efficacy measure related to obtaining
follow-up care after receiving results suspicious for cancer.
The instrument was initially developed and pilot tested by an NCI-funded study
titled “Patient Navigation Research Project.” A team of investigators developed the
measure to assess participants’ perceived capability to obtaining follow up care after
getting abnormal results suspicious for cancer. The measure was developed in English
and Spanish language. By conducting my research project, I hope to refine the instrument
items and gather evidence of the instrument’s psychometric properties. In order to do
that, I will conduct content validity assessments. As you know, content validity is an
evaluation of whether items in a scale are relevant and measure all aspects of a construct.
I would like to ask for your assistance in serving as a content validity reviewer
based on your expertise on the topic of self-efficacy, your ample experience with
instrument development, and your ability to speak Spanish fluently. If you agree to take
part, I will send you an email containing a brief rating form. The form asks for you to rate
each item based on its relation to the underlying construct of self-efficacy, rate each
item’s level of clarity and provide suggestions for revisions. This form takes about 15-20
minutes to complete. Once you have completed the form, I will ask you to return it to me
electronically. Upon the completion of my thesis project, and if you are interested, I will
be happy to provide you with a summary of the results and a copy of the final instrument.
Thank you so much for considering my request for assistance with my thesis
project. Please let me know your decision at your earliest convenience. Please feel free
to contact me should you have any questions regarding the content validity evaluation or
my project.
Sincerely,

Mariana Arévalo
MPH candidate, Community and Family Health
University of South Florida
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APPENDIX L:
ENGLISH CONTENT VALIDITY EXPERT SCORING CARD
INSTRUCTIONS: This form is designed to evaluate the content validity of an
instrument measuring self-efficacy for obtaining follow-up care after receiving an
abnormality suspicious for cancer.
Construct of interest: Self-efficacy is an individual’s perceived capacity to execute a
desired behavior.
Please rate each item as follows:


Column 1: Please rate the level of each item’s relevance to the construct of interest on
a scale of 1-4, where 1= “Not relevant at all” 2= “Slightly relevant” 3=“Somewhat
relevant” 4 =“Relevant” as it relates to the construct of self-efficacy.
o The space provided is for you to comment on the item or to suggest
revisions



Column 2: Please indicate the level of clarity for each item also on a 4-point scale,
where 1= “Item is not clear” 2= “Item needs major revisions to be clear”;
3=”Item needs minor revisions to be clear”; 4= “Item is clear”



Column 3: Finally, please evaluate the comprehensiveness of the entire instrument by
indicating items that should be deleted based on redundancy, cultural or linguistic
acceptability.

Thank you for your time.

ITEM

1= Not relevant at all
2= Slightly relevant
3=Somewhat relevant
4 =Relevant
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1= Item is not clear
2= Needs major
revisions to be
clear
3=Needs minor
revisions to be
clear
4= Item is clear

Other comments
or suggestions to
delete items

APPENDIX M:
SPANISH CONTENT VALIDITY EXPERT SCORING CARD
INSTRUCCIONES: El siguiente formulario fue diseñado para evaluar la validez del
contenido de un instrumento que mide el nivel de autoeficacia de una persona al obtener
cuidados médicos de seguimiento después de obtener resultados anormales en una prueba
de detección del cáncer.
El dominio de interés del instrumento es la autoeficacia, la cual es la capacidad de una
persona para ejecutar un comportamiento deseado.
Por favor califique cada ítem del instrumento de la siguiente forma:


Columna 1: En una escala de 1 a 4, por favor indique el nivel de relevancia de cada
ítem con respecto al dominio de interés (i.e. autoeficacia) tomando en cuenta los
siguientes valores: 1= “No tiene relevancia”; 2= “Es poco relevante” 3=“Es algo
relevante” 4 =“Es relevante.”
o El espacio en blanco bajo cada cuadro puede ser utilizado para escribir sus
comentarios acerca de cada ítem ó para sus sugerencias acerca de éste.



Columna 2: De forma similar en una escala de 1 a 4, por favor indique el nivel de
claridad de cada ítem utilizando los siguientes valores: 1= “ítem no es claro” 2=
“ítem necesita correcciones/ajustes mayores para ser claro”; 3= “ítem necesita
correcciones/ajustes menores para ser claro”; 4= “ítem es claro”



Columna 3: Finalmente, por favor evalúe la complejidad del instrumento indicando si
considera que algún ítem deberia de ser eliminado por ser redundante ó por falta de
consideración de cuestiones culturales o linguisticas.

Muchas gracias por su tiempo.

ítem

1= No tiene relevancia
2= Es poco relevante
3= Es algo relevante
4 =Es relevante

1= ítem no es claro
2= ítem necesita
correcciones/ajustes
mayores para ser claro
3= ítem necesita
correcciones/ajustes
menores para ser claro
4=ítem es claro
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Otros comentarios
o sugerencias

APPENDIX N:
QUALITATIVE DATA FROM CONTENT VALIDITY RATING FORM
Table A. Comments gathered from content validity reviewers (English and Spanish combined)
item
COMMENTS
#
Item Description
English


2



I can talk to my health care
provider even if he or she
does not speak my
language.







this is related to SE, but this is depending on factors
outside of the individual’s control (i.e. interpreter).
This may be tricky.
I would be helpful to know the response options for
the questions. I am assuming they are rating their
confidence on a likert-type scale; item is clear but
I’m not sure it makes sense. If he or she doesn’t
speak (and I’m assuming understand, too) the
language, what does it mean to “talk” to them?
I would remove this item. OR, at the very least
consider changing it to talk with, if you do in fact
want to imply a conversation.
Is this supposed to be in Spanish?
Should the focus be the use of an interpreter?
Reword to: I can request an interpreter if my PCP
does not speak my language
They do not speak the same language
Why is the word “talk” used in one sentence and
“speak in the other? I think the concept is to
communicate – is it possible to communicate?
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COMMENTS
Spanish

Aclarar: puedo encontrar la manera
para comunicarme con un…
o 4. Consider using aunque
instead of incluso si

Table A. Comments gathered from content validity reviewers (English and Spanish combined)
item
COMMENTS
#
Item Description
English


3

I can get transportation to
health care appointments
even if I cannot drive a car.





13


I can talk to my health care
provider even if I have
difficulty understanding him
or her.





You may still leave the appointment without the
necessary information. Consider rewording.
Consider changing it to “talk with” if you do, in fact,
want to imply a conversation. I can talk to anybody
regardless of whether or not I understand them.
Is this different than language question? Is this
getting at medical terms?
Same as #2
Again, I think the construct is communication not
“talk”
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COMMENTS
Spanish

You make assumptions. Perhaps best to
say do you have transportation Yes/No.
If no, how do you get to your medical
visits… that way you get more
information.
Explicar como, “Puedo recurrir a
recursos locales y conseguir…” o
“puedo recurrir a mis familiars”
Consider using aunque instead of
incluso si
What do you mean “organizar” do you
mean hacer?
“incluso” parts are wordy. Perhaps
rephrase it.
Porque razón? Debido al idioma?
Debido a los terminus medicos?
Consider using aunque instead of
incluso

Table A. Continued
item
#
Item Description

COMMENTS
English


16



I can fill out forms at the
clinic even if I have trouble
writing.





27
I can get transportation to
health care appointments
even if there is no bus.
41

I can get to a health care
appointment even if it is far
away.










COMMENTS
Spanish

Delete. Someone may have trouble writing because
they cannot speak the language.
Not sure about this. Consider removing. Filling out
forms is not essential to follow-up care (although
providers want patients to do it). Furthermore, what
do you mean “trouble writing” Do you mean it is
difficult to move hands in a way that allows me to
write clearly?” or “I don’t know how to construct a
sentence” or “I don’t know how to spell?” or
“something else?”
Trouble writing, is this intended to be a literacy
skill-related item? Reword to; I’m unable to write.
Reading or writing
I wonder if people who have trouble writing would
describe it like that? Maybe it is difficulty writing
not “trouble”



Delete. Similar to above and below.
Assumes that some people can’t walk or take a taxi.
May be add “van” or “taxi” and if this is going
outside of FL I would add “train, subway”
Public transportation
Delete. Similar to above.
Far is a relative term in urban vs rural settings
Consider merging with question #51.
Maybe say “not within walking distance”
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This implies that they have someone
that can help them – why not ask if
they have someone that can help them.
existe mucho analfabetismo en la
población latina hay que aclarar esto.
“Puedo encontrar la manera de llenar
formularios”
“unique no puedo escribir muy bien”

Redundant. Similar to # 3 Combine or
choose one or the other.
Duplicate again
Consider using aunque instead of
incluso
Consider using aunque instead of
incluso

Table A. Continued
item
#

Item Description

English


42
I can find people who can
help me get to my clinic
appointments.





44

I can get medicines even if I
have trouble paying for
them.

45

I can get follow-up health
care even if I do not
understand the health
problem

46
I can get follow-up health
care even if I have trouble
paying for it.

COMMENTS

COMMENTS
















Spanish

Consider prefacing (or ending) this question with “if
needed”, since some people won’t need help getting
to appointments.
Just because you can find them doesn’t mean that
they would help.
Is the idea to find people or to have a network of
people who can assist?
This is relevant to SE, but also contingent upon so
many other factors. Usually you have to be income
eligible to get assistance. What about those who are
above the threshold?
Strictly speaking, your definition of follow-up care
did not include medications
If someone can’t pay for medicines, this is an issue.
Reword to: even if I cannot afford to pay for it.
Pair with 46
May be some of these questions should start saying
“I know how to”?
Again, so what if you can, will you?
Would someone get follow-up for something they
don’t understand?
Change to “my health problem”
Again a lot of contingencies.
Again, so what if you can, will you?
Relevant
Reword to: even if I cannot afford to pay for it.
I’m not crazy about the word “trouble” may be
difficulty?
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Wording seems odd.
Puedo recurir a recursos locales para
obtener…
Aunque se me haga…

“Puedo pedir explicaciones si no
entiendo el problema medico que
tengo/padezco.”
Consider using aunque instead of
incluso
Consider using aunque instead of
incluso; also, awkward phrasing,
consider “se me hace dificil”

Table A. Continued
item
#
Item Description

COMMENTS
English




47

I can get follow-up health
care even if I get frustrated
with things that go wrong at
the clinic.







49
I can get follow-up health
care even if I usually use
natural remedies to treat
disease.






51
I can get to a health care
appointment that is in a
place I have never been to.




Is frustrated a universal term. Consider rewording.
Again, so what if you can, will you?
Frustration is culturally nuanced term, frustrated
because of language barriers could be different that
other reasons
Is this question related to the quality of care received
at the clinic? Too much waiting time, unhappy about
quality of services, etc. Delete.
Maybe different than frustrated/ also frustrated is
kind of vague.
The can word is problematic – technically can
means able to but not necessarily will. For example,
I can count to ten in other languages, but I won’t do
it. I think you want to know if people will do things,
not if they can.
I would list examples of natural remedies or other
terms like “herbal treatments?” to be clear what you
mean. You might also say “even if usually use only
natural remedies”
Follow-up care wouldn’t be denied if someone using
the natural remedies implies such in question.
Not sure if you really need this.
I will get….
Note that this one of only two questions, I think, that
do not contain “even if”
Good question, maybe revise wording, “that is in a
location new to me”
This sentence is very grammatically incorrect. It
should read “ I can get to a health care appointment
in a place I have never been.”
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COMMENTS
Spanish








Can you give examples for “van bien
en la clínica”
el funcionamiento o proceso de la
Clinica
Consider using aunque instead of
incluso

4. Consider using aunque instead of
incluso

APPENDIX O:
REVISED ENGLISH-LANGUAGE ITEMS
Table B. Revised English-language items

Variable Original item

Comments/suggestions

Revised item

bse44

I can get medicines
even if I have trouble
paying for them.

Substitute “trouble” for “difficulty”

I can get medicines even if I
have difficulty paying for
them.

bse46

I can get follow-up
health care even if I
have trouble paying for
it.

Substitute “trouble” for “difficulty”

I can get follow-up health
care even if I have difficulty
paying for it.

bse3

I can get transportation
to health care
appointments even if I
cannot drive a car.

116

Table B. Continued
Variable Original item

bse27

I can get transportation
to health care
appointments even if
there is no bus.

bse42

I can find people who
can help me get to my
clinic appointments.

bse41

I can get to a health
care appointment even
if it is far away.

bse47

I can get follow-up
health care even if I
get frustrated with
things that go wrong at
the clinic.

bse51

I can get to a health
care appointment that
is in a place I have
never been to.

Comments/suggestions

Revised item

Add “van” or “taxi” and perhaps
“train and subway”for cities outside of
Florida

I can get to my health care
appointments even if there
is no public transportation
(bus, train, subway, etc).

Far is relative term in urban vs rural
settings

I can get to a health care
appointment even if it is not
within walking distance.

This sentence is very grammatically
incorrect. Revise.

I can get to a health care
appointment in a place I
have never been.
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Table B. Continued
Variable Original item

Comments/suggestions

Revised item

bse13

I can talk to my health
care provider even if I
have difficulty
understanding him or
her.

Is this different than language
question? Is this getting at medical
terminology?

I can ask questions to my
health care provider if I
have difficulty
understanding him or her.

bse2

I can talk to my health
care provider even if
he or she does not
speak my language.

Should the focus be the use of an
interpreter?

I can request an interpreter
if my health care provider
does not speak my
language.

bse16

I can fill out forms at
the clinic even if I
have trouble writing.

Someone may have trouble writing
because they cannot speak the
language or because they are injured

I can fill out forms at the
clinic even if I am unable to
write.

bse45

I can get follow-up
health care even if I do
not understand the
health problem.
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APPENDIX P:
REVISED SPANISH-LANGUAGE ITEMS
Table C. Revised Spanish-language items

Variable Original item

Comments/suggestions

Revised item

bse44

Puedo obtener
medicinas incluso si
me es difícil pagarlas

Wording seems odd.
Reword to: aunque se me haga

Puedo conseguir medicinas aunque me sea
difícil pagarlas

bse46

Puedo obtener
cuidados médicos de
seguimiento incluso si
me es difícil pagarlos

Awkward phrasing. Consider using “se
me hace difícil”

Puedo obtener cuidados médicos de
seguimiento aunque se me haga difícil
pagarlos

bse3

Puedo conseguir
transporte para ir a las
citas médicas incluso
si no puedo manejar un
auto

Consider using aunque instead of
incluso si

Puedo conseguir transporte para ir a las citas
médicas aunque no pueda manejar un auto
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Table C. Continued

Variable Original item

Comments/suggestions

Revised item

Revised based on English revisions

Puedo llegar a mis citas médicas aunque no
haya transporte público (autobús, tren, tren
subterráneo, etc.).

bse27

Puedo conseguir
transporte para ir a las
citas médicas incluso
si no hay guagua
(autobús).

bse42

Puedo encontrar
personas que pueden
ayudarme a llegar a
mis citas de la clínica

bse41

Puedo ir a una cita
médica incluso si está
lejos

Revised based on English item

Puedo ir a una cita médica aunque no esté
en un lugar a donde me pueda ir a pie

bse47

Puedo obtener
cuidados médicos de
seguimiento incluso si
me frustran las cosas
que no van bien en la
clínica.

Consider using aunque instead of
incluso si

Puedo obtener cuidados médicos de
seguimiento aunque me frustran las cosas
que no van bien en la clínica.
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Table C. Continued
Variable Original item

bse13

Puedo organizar una
cita para hablar con mi
profesional de la salud
incluso si tengo
dificultad para
entenderle.

bse2

Puedo hablar con un
profesional de la salud
incluso si éste no habla
mi idioma

bse16

bse45

Puedo llenar
formularios en la
clínica incluso si tengo
problemas para
escribir
Puedo obtener
cuidados médicos de
seguimiento incluso si
no entiendo el
problema médico

Comments/suggestions

Revised item

Revised based on English revisions

Puedo hacerle preguntas a mi profesional de
la salud si tengo dificultad para entenderle.

Revised based on English revisions

Puedo pedir un intérprete si mi profesional
de la salud no habla mi idioma

Revised based on English revisions

Puedo llenar formularios en la clínica
aunque no sepa escribir

…problema médico que tengo/padezco

Puedo obtener cuidados médicos de
seguimiento aunque no entienda el
problema médico que tengo
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APPENDIX Q:
INSTITUTIONAL REVIEW BOARD APPROVAL LETTER
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